Filed
Pursuant to Rule 424(b)(5)
Registration
No. 333-260666
PROSPECTUS
SUPPLEMENT
(To
Prospectus dated November 5, 2021)
4,181,821
Shares
Amesite
Inc.
Common
Stock
We
are offering 4,181,821 shares of our common stock, $0.0001 par value per share, pursuant to this prospectus supplement and accompanying
prospectus at a price per share equal to $0.55. In a concurrent private placement, we are also selling to the purchasers of shares of
our common stock in this offering warrants to purchase an aggregate of 4,181,821 shares of our common stock, or the Warrants. The Warrants
issued in the private placement and the shares of our common stock issuable upon the exercise of the Warrants are being offered pursuant
to the exemption provided in Section 4(a)(2) under the Securities Act and Rule 506(b) promulgated thereunder, and they are not being
offered pursuant to this prospectus supplement and the accompanying prospectus.
The
Warrant shall be initially exercisable after the six-month anniversary of the issuance date at an exercise price of $0.82 per share and
have a term of exercise equal to five and one-half years from the issuance date.
Our
common stock is traded on the Nasdaq Capital Market under the symbol “AMST.” On August 29, 2022, the last reported sale price
of our common stock on the Nasdaq Capital Market was $0.83 per share.
Investing
in our securities involves a high degree of risk. You should read the ‘‘Risk Factors’’ section beginning on page
S-10 of this prospectus supplement and page 9 of the accompanying prospectus and in the documents incorporated by reference in this
prospectus supplement for a discussion of factors to consider before deciding to invest in our common stock.
| |
Per Share | | |
Total | |
Offering price | |
$ | 0.55 | | |
$ | 2,300,001 | |
Placement agent fees (1) | |
$ | 0.044 | | |
$ | 184,000 | |
Proceeds, before expenses, to us | |
$ | 0.506 | | |
$ | 2,116,001 | |
(1) |
In
addition to the placement agent’s fees of 8.0% of the public offering price, we have agreed to pay the placement agent a cash
management fee of 1% of the gross proceeds from the sales of common stock sold in the offering. We have also agreed to issue the
placement agent or its designees warrants to purchase a number of shares of common stock equal to 5% of the shares of common stock
sold in this offering and to reimburse the placement agent for certain offering-related expenses. See “Plan of
Distribution” beginning on page S-17 of this prospectus supplement for additional information regarding underwriting
discounts, commissions and estimated expenses. |
Neither
the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined
if this prospectus supplement or the accompanying prospectus is truthful or complete. Any representation to the contrary is a criminal
offense.
The placement agent expects to deliver the shares
on or about September 1, 2022.
_________________
Sole
Book-Running Manager
Laidlaw&
Company (UK) Ltd.
The
date of this prospectus supplement is August 30, 2022.
TABLE
OF CONTENTS
ABOUT
THIS PROSPECTUS SUPPLEMENT
This
prospectus supplement and the accompanying prospectus are part of a registration statement on Form S-3 (File No. 333-260666) that we
filed with the Securities and Exchange Commission, or SEC, on November 1, 2021, and that was declared effective by the SEC on November
5, 2021 using a “shelf” registration process. This document is in two parts. The first part is this prospectus supplement,
which describes the specific terms of this offering and also adds to and updates information contained in the accompanying prospectus
and the documents incorporated by reference herein. The second part, the accompanying prospectus, provides more general information,
some of which may not apply to this offering. Generally, when we refer to this prospectus, we are referring to both parts of this document
combined. To the extent there is a conflict between the information contained in this prospectus supplement and the information contained
in the accompanying prospectus or any document incorporated by reference therein filed prior to the date of this prospectus supplement,
you should rely on the information in this prospectus supplement. If any statement in one of these documents is inconsistent with a statement
in another document having a later date—for example, a document incorporated by reference in the accompanying prospectus—the
statement in the document having the later date modifies or supersedes the earlier statement.
We
further note that the representations, warranties and covenants made by us in any agreement that is filed as an exhibit to any document
that is incorporated by reference herein were made solely for the benefit of the parties to such agreement, including, in some cases,
for the purpose of allocating risk among the parties to such agreements, and should not be deemed to be a representation, warranty or
covenant to you. Moreover, such representations, warranties or covenants were accurate only as of the date when made. Accordingly, such
representations, warranties and covenants should not be relied on as accurately representing the current state of our affairs.
You
should rely only on the information contained in this prospectus supplement
or the accompanying prospectus or incorporated by reference herein. We have not authorized, and the placement agent has not authorized,
anyone to provide you with information that is different. The information contained in this prospectus supplement or the accompanying
prospectus or incorporated by reference herein or therein is accurate only as of the respective dates thereof, regardless of the time
of delivery of this prospectus supplement and the accompanying prospectus or of any sale of our common stock.
This
prospectus supplement and the accompanying prospectus contain summaries of certain provisions contained in some of the documents described
herein, but reference is made to the actual documents for complete information. All of the summaries are qualified in their entirety
by the actual documents. Copies of some of the documents referred to herein have been filed, will be filed or will be incorporated herein
by reference as exhibits to the registration statement, and you may obtain copies of those documents as described below in the section
entitled “Where You Can Find More Information.”
It
is important for you to read and consider all information contained in this prospectus supplement and the accompanying prospectus, including
the documents incorporated by reference herein and therein, in making your investment decision. You should also read and consider the
information in the documents to which we have referred you in the sections entitled “Where You Can Find More Information”
and “Information Incorporated By Reference” in this prospectus supplement and in the accompanying prospectus, respectively.
This
prospectus supplement and the accompanying prospectus contain and incorporate by reference market data and industry statistics and forecasts
that are based on independent industry publications and other publicly-available information. Although we believe these sources are reliable,
we do not guarantee the accuracy or completeness of this information and we have not independently verified this information. Although
we are not aware of any misstatements regarding the market and industry data presented in this prospectus supplement, accompanying prospectus
or the documents incorporated herein by reference, these estimates involve risks and uncertainties and are subject to change based on
various factors, including those discussed in the section entitled “Risk Factors” in this prospectus supplement and the accompanying
prospectus, and under similar headings in the other documents that are incorporated herein by reference. Accordingly, investors should
not place undue reliance on this information.
We
are offering to sell, and seeking offers to buy, the securities offered by this prospectus supplement only in jurisdictions where offers
and sales are permitted. The distribution of this prospectus supplement and the accompanying prospectus and the offering of the securities
offered by this prospectus supplement in certain jurisdictions may be restricted by law. Persons outside the United States who come into
possession of this prospectus supplement and the accompanying prospectus must inform themselves about, and observe any restrictions relating
to, the offering of the common stock and the distribution of this prospectus supplement and the accompanying prospectus outside the United
States. This prospectus supplement and the accompanying prospectus do not constitute, and may not be used in connection with, an offer
to sell, or a solicitation of an offer to buy, any securities offered by this prospectus supplement and the accompanying prospectus by
any person in any jurisdiction in which it is unlawful for such person to make such an offer or solicitation.
All
references in this prospectus supplement and the accompanying prospectus to “Amesite,” the “Company,” “we,”
“us,” “our,” or similar terms refer to Amesite Inc. and its subsidiaries taken as a whole, except where the context
otherwise requires or as otherwise indicated. Amesite’s name and logo are either registered trademarks or trademarks of Amesite
Inc. in the United States and/or other countries. All other trademarks, service marks or other tradenames appearing in this prospectus
supplement and the accompanying prospectus are the property of their respective owners.
This
prospectus supplement includes our trademarks, trade names and service marks, such as AMESITETM , LEARNING COMMUNITY
ENVIRONMENTTM and KEEP LEARNINGTM, which is protected under applicable intellectual property laws and are
the property of Amesite Inc., or its subsidiaries. Solely for convenience, trademarks, trade names and service marks referred to in this
prospectus supplement may appear without the ®, ™ or SM symbols, but such references are not intended to indicate, in any way,
that we will not assert, to the fullest extent under applicable law, our rights or the right of the applicable licensor to these trademarks,
trade names and service marks. We do not intend our use or display of other parties’ trademarks, trade names or service marks to
imply, and such use or display should not be construed to imply, a relationship with, or endorsement or sponsorship of us by, these other
parties.
PROSPECTUS
SUPPLEMENT SUMMARY
This
summary highlights selected information about us, this offering and information appearing elsewhere in this prospectus supplement, in
the accompanying prospectus and in the documents incorporated by reference herein and therein. This summary is not complete and does
not contain all the information you should consider before investing in our securities pursuant to this prospectus supplement and the
accompanying prospectus. Before making an investment decision, to fully understand this offering and its consequences to you, you should
carefully read this entire prospectus supplement and the accompanying prospectus, including “Risk Factors,” the financial
statements, and related notes, and the other information incorporated by reference herein and therein.
Overview
Overview
Amesite’s
smart, intuitive learning environments help organizations thrive. Amesite is a high tech artificial intelligence software company offering
a cloud-based platform and content creation services for business and university-delivered education and upskilling. Amesite-offered
courses and programs are branded to our customers. Amesite uses artificial intelligence technologies to provide customized environments
for learners, easy-to-manage interfaces for instructors, and greater accessibility for learners in the US education market and beyond.
The Company leverages existing institutional infrastructures, adding mass customization and cutting-edge technology to provide cost-effective,
scalable and engaging experiences for learners anywhere.
Businesses
need learning and development (L&D) platforms to upskill workers, to improve retention and enable them to achieve their goals.
We
are passionate about improving the learner experience and learner outcomes in online learning products, and improving our customers’
ability to create and deliver both. We are focused on creating the best possible technology solutions and have been awarded an innovation
award for our product. We are committed to our team, and have been recognized with 10 workplace excellence awards, including four national
awards.
Our
Strategy
We
deliver Learning Community Environments (LCEs) to businesses and educational institutions (EIs) that enable them to offer branded learning
products to their employees or students with ease. Our business model offers flexibility for our customers. Our customers license our
platform and can also contract with to us to create and maintain customized learning products, or easily launch their own learning products
on the platform. We have entered into master service agreements with our customers, including, but not limited to, universities such
as Wayne State University and enterprises such as The Henry Ford. These agreements include statements of work detailing the services
to be rendered and programs or products to be delivered on the platform. We use the proprietary data we collect on learner behavior and
responses with their consent, to deliver to learners engaging, effective courses and programs. Our customers gain efficiency, flexibility
and can generate high return on investment and revenue through partnership with us, because of the speed, flexibility, effectiveness
and scalability of the LCEs we build for them.
Businesses
need learning systems that enable them to upskill people quickly and efficiently. Retention and execution of strategic plans require
that employees stay engaged, and learn effectively. Universities need to be able to launch programs that upskill their alumni and other
professionals, accessibly and scalably. Government needs to be able to offer learning programs that allow job seekers to advance skills.
Amesite’s cloud-based platform addresses all of these key needs.
Our
Proprietary Technology
We
believe that online learning products are essential for accessibility, engagement and scalability for businesses and EIs alike. We utilize
artificial intelligence to achieve improved engagement, and continuous integration of current, qualified information into our learning
products.
Our
technology utilizes a flexible and scalable full stack solution, with robust tools powering front-end technology. Our code architecture
offers outstanding accessibility and agility for engineers, using best-in-class languages for both client and server-side functions.
We also use tools employed by many high-end platforms. Our architecture enables us to achieve full integration of best-in-class third
party tools, and custom-built features, delivering on-demand and as-needed, such as leading calendar platform integrations, and high
quality, encrypted video calling.
Our
architecture enables us to utilize artificial intelligence algorithms to ultimately improve learning outcomes. Much as artificial
intelligence algorithms presently recognize and respond to natural language on commercial platforms, predict behaviors and deliver suggestions,
our algorithms have been developed to assist learners in accessing, utilizing and remaining engaged with platform content, their instructors
and their peers.
We
generate content for our customers using the highest standards in business and higher education, and our business model enables us to
deliver content for our customers efficiently and rapidly. Rapidly evolving technology has driven the need to continuously upskill
students and workforces, and we use the highest possible standards to deliver this content according to customer needs. This substantially
reduces the time it takes for traditional program creation by businesses or EIs.
We
market to our customers, and enable them to offer and monetize learning products, or to deliver learning products to their own employees
efficiently and cost effectively. Our customers want the capability of delivery to their own customers, and are best able to
market to them. We deliver the content and technology to enable this.
We
protect and utilize learner data solely to improve learning outcomes. Learner data is collected with learner permission, and
information about learner behavior, study preferences and preference for types of material delivered as part of learning products, will
be used to improve learning outcomes and learner experiences. We will validate algorithms using both offline and online testing. By correlating
learner behaviors with specific outcomes as identified by qualified instructors, we will train our algorithms specifically for important
learning outcomes, enabling it to be a useful tool for instructors. We believe that the combinations of information that will be collected
through our educational products, and outcomes measured using our online learning products will be unique, and constantly improving.
We will never sell or distribute our learner data to third parties without the explicit permission of learners. We will not deliver unwanted
content or advertising to learners or to customer personnel. Our proprietary technology is developed solely for purposes of improving
learner experiences and outcomes, and improving the ability of our customers to deliver outstanding educational products.
Our
Research and Development Programs
We
use advanced technologies to create effective and accessible learning environments. We seek to improve learning at many levels, including
college and professional. Our research and development programs will expand continuously based on learner preferences, outcomes and the
desires of our customers. Some of these will include:
|
● |
Improvements in learner
engagement with cloud-based platforms. We will continuously gather data on how learners engage with us and other online platforms,
and conduct research and development to create and incorporate useful tools for learning on our platform. |
|
● |
Improvements in instructor
experience using our platform. We will continuously develop tools designed to improve the ability of our customers to deliver
timely and relevant content, deliver assessments which are fair, correctly represent educational objectives and give repeatable outcomes
when employed on our platform. |
|
● |
Integration of new technology
in the delivery of learning products. A “technology stack” is a combination of software products and programming
languages used to create our platform. We will continuously develop improvements to our technology stack, inventing and integrating
best-in-class online engagement features. These will range from invention of novel user experience features, to integration of capabilities
offered by other vendors and developers. |
|
● |
Qualification of information
for use by learners in all sectors. We plan to provide both our customers and our learners with the constantly improving ability
to find and integrate qualified information into products on our platform, and maximize learner ability to utilize qualified information,
designed to offer learners the most carefully curated, most relevant, timely and engaging materials in every discipline in which
we offer products. |
Our
Intellectual Property
Our
intellectual property rights include patent applications, trade secrets, trademark rights, and contractual agreements. Our patent applications
are directed to our proprietary technology, including an artificial intelligence platform for learning, and will seek patent protection
for our designs, development, and related alternatives by filing and prosecuting patent applications in the U.S. and other countries
as appropriate.
We
have received two U.S. patents and currently have five pending U.S. patent applications, including one to cover the artificial intelligence
platform, and others related to security, power consumption, blockchain, design and other technologies, including methods and systems.
Any patent issued from these applications are expected to expire in 2038, not including any applicable patent term adjustment or extension
or design patents.
We
possess trade secret protection for our source codes, methodologies, algorithms, and techniques directed to other aspects of our artificial
intelligence learning platform. We currently have two trademarks what are registered with the United States Patent and Trademark Office
(USPTO) for AMESITE® and LEARNING COMMUNITY ENVIRONMENT® (Reg. Nos. 6486538, 5875317, and 6783820), and have received a Notice
of Allowance from the USPTO related to our trademark application for our KEEP LEARNING℠ trademark (Serial No. 88766887). We have
also secured domain names, including amesite.com, amesite.co, amesite.net, and others.
We
ensure that we own intellectual property created for us by signing agreements with employees, independent contractors, consultants, companies,
and any other third party that creates intellectual property for us or that assign any intellectual property rights to us. Portions of
our platform may rely upon third-party licensed intellectual property.
We
have established business procedures designed to maintain the confidentiality of our proprietary information, including the use of confidentiality
agreements with employees, independent contractors, consultants and entities with which we conduct business.
Competition
The
online and software industries for higher education are characterized by rapid evolution of technologies, fierce competition, government
regulation, and strong defense of intellectual property. The overall market for technology solutions that enable providers to deliver
education online is highly fragmented, rapidly evolving and subject to changing technology, shifting needs of learners and educators
and frequent introductions of new methods of delivering education online. While we believe that our platform, programs, technology, knowledge,
experience, and resources provide us with competitive advantages, we face competition from major online companies, academic institutions,
governmental agencies, and public and private research institutions, among others.
Any
learning product that we successfully develop and commercialize will compete with current learning products. Key product features that
would affect our ability to effectively compete with other course offerings include efficiency, security and convenience, and availability.
Our competitors fall primarily into the following groups:
|
● |
Online Program Management
(OPM) firms, who create and launch educational products for EIs and businesses, using either their own or others’ Learning
Management Systems (LMSs). |
|
● |
Learning Management System
(LMS) technology firms, who offer technology platforms suitable for offering online educational or training products |
|
● |
Learning product aggregators,
who offer multiple institutions’ or businesses’ learning products on online platforms for direct purchase by learners,
or through licenses by institutions. |
Many
of the organizations against which we may compete have significantly greater financial resources and expertise in education, software
design and development, and have already obtained approvals and marketing approved products. Smaller or early-stage companies may also
prove to be significant competitors, particularly through collaborative arrangements with large and established companies. These competitors
also compete with us in recruiting and retaining qualified engineers, scientists, and management personnel, as well as in acquiring technologies
complementary to, or necessary for, our programs.
We
expect that the competitive landscape will continue to expand as the market for online programs at nonprofit institutions matures. We
believe the principal competitive factors in our market include the following:
|
● |
brand awareness and reputation; |
|
● |
ability of online programs
to deliver desired learner outcomes; |
|
● |
robustness and evolution
of technology offering; and |
|
● |
breadth and depth of service
offering. |
We
believe we will compete favorably on the basis of these factors, but substantial risks remain. Our ability to remain competitive will
depend, to a great extent, on our ability to consistently deliver high-quality offerings; meet client needs for content development;
attract, support and retain learners; and deliver desired outcomes for our customers and their learners.
Government
Regulation and Product Approval
The
education industry is heavily regulated. Institutions of higher education that award degrees and certificates to signify the successful
completion of an academic program are subject to regulation from three primary entities, namely, the U.S. Department of Education (the
“DOE”), accrediting agencies, and state licensing authorities. Each of these entities promulgates and enforces its own laws,
regulations and standards, which we refer to collectively as education laws.
We
contract with higher education institutions that are subject to education laws. In addition, we are required to comply with certain education
laws as a result of our role as a service provider to institutions of higher education, either directly or indirectly through our contractual
arrangements with customers. Our failure, or that of our customers, to comply with education laws could adversely impact our operations.
As a result, we work closely with our customers to maintain compliance with education laws.
We
will abide by education laws, including incentive compensation rules, misrepresentation rules, accreditation rules and standards, among
state and federal regulations. We also closely monitor state law developments and we will work closely with our customers to assist them
with obtaining any required approvals.
Our
activities on behalf of our customers are also subject to other federal and state laws. These regulations include, but are not limited
to, consumer marketing and unfair trade practices laws and regulations, including those promulgated and enforced by the Federal Trade
Commission, as well as federal and state data protection and privacy requirements.
Sales
and Marketing
We
plan to grow our sales and marketing program as we build our customer base, advancing from our small, direct sales force to a distribution
network that has existing relationships with colleges, universities, non-profit organizations and businesses.
We
have developed a branding strategy to introduce and support our platform. The strategy includes direct marketing methods to educational
institutions, non-profit organizations that deliver learning programs, and businesses. Our marketing strategy also includes sponsored
and invited presentations at key conferences and workshops, with the intent to introduce our solutions to organizations seeking edtech
software. We plan to pursue selected business opportunities, including joint developments, collaborations and acquisitions that have
the potential to build sales more rapidly. We aim to develop and pursue such opportunities on a consistent basis to grow the Company.
Board
of Advisors
Dennis
Bernard, Chairman of the Board of Advisors
Mr.
Bernard is the founder and President of Bernard Financial Group and Bernard Financial Servicing Group (“BFG”). BFG is the
largest commercial mortgage banking firm in Michigan, financing, on average, over $1.0 billion annually. Mr. Bernard has been involved
with over 1,200 commercial real estate financial transactions totaling over $18.6 billion. Mr. Bernard specializes in both debt and equity
placement with commercial lenders and institutional joint venture participants.
Martha
A. Darling, Member
Over
the past 22 years, Ms. Darling has held volunteer leadership roles nationally and in Michigan and has consulted on education policy issues
for the National Academy of Sciences and other non-profit organizations. Prior to moving to Ann Arbor, Ms. Darling was a Senior Program
Manager at The Boeing Company in Seattle, from which she retired in 1998. She joined Boeing in 1987, with assignments in 747 Program
Management, Government Affairs and Boeing’s Corporate Offices, where she supported the chief executive officer and other executives.
Previously, she was Vice President for Strategic Planning at Seattle-First National Bank and then, on loan from Seattle-First, she served
as Executive Director of the Washington Business Roundtable’s Education Study. From 1977 to 1982 she served in Washington, D.C.
as White House Fellow and Executive Assistant to Secretary of the Treasury W. Michael Blumenthal and then as Senior Legislative Aide
to U.S. Senator Bill Bradley. She has also served as Special Assistant to the Governor of Washington, Research Social Scientist at the
Battelle Seattle Research Center, and was a free-lance consultant to the Organization for Economic Cooperation and Development and other
international organizations for four years in Paris.
Theodore
l. Spencer, Member
Mr.
Spencer is Senior Advisor on Admissions Outreach at the University of Michigan. Prior to September 2014, he was Associate Vice Provost
and Executive Director of Undergraduate Admissions. Before joining Michigan in 1989, he was an Associate Director of Admissions at the
United States Air Force Academy. He is a graduate of the Military Air War College and was one of thirty-five Air Force recruiting commanders
in the United States. He is a retired Lieutenant Colonel in the United States Air Force. Early in his career, he was a salesman for the
IBM Corporation in the City of Detroit. Ted has presented at numerous professional conferences state-wide, nationally and internationally,
and has written and published articles on the college admissions process. He has received numerous awards, and was recognized as the
Point Man on Diversity Defense for affirmative action in college admissions. He has previously served as a Trustee for the College Board
and on the faculty for the Harvard Summer Institute on College Admissions. Ted holds a M.S. degree in sociology from Pepperdine University
and a B.S. in political science from Tennessee State University.
Human
Capital Management
General
Information About Our Human Capital Resources
As
of March 31, 2021, we have 26 total employees, comprised of 22 full-time employees and 4 consultants. We intend to hire additional staff
and to engage consultants in general administration on an as-needed basis. We also intend to engage experts in operations, finance and
general business to advise us in various capacities. None of our employees are covered by a collective bargaining agreement, and we believe
our relationship with our employees is good to excellent.
Our
Culture
Amesite’s
mission is to improve the way the world learns. We are passionate about understanding the needs of our learners, and we work hard to
build products that deliver—for each and every one. We also believe that supporting our team with a wonderful environment supports
and powers us to accomplish our goals. Our values are summarized in our beats—the guideposts for our culture.
|
● |
Measurement beats conjecture |
|
● |
Humility beats arrogance |
|
● |
Honesty beats politeness |
|
● |
Transparency beats manipulation |
|
● |
Passion beats indifference |
|
● |
Optimism beats cynicism |
Diversity
and Inclusion
To
truly change how the world learns and improve the learning process and environment for learners across the world, we need to work with
a diversity of partners as well as have a diverse workforce. We also must operate with a high degree of awareness of evolving social
conditions, social justice – and create policy accordingly. We acknowledge that these measures evolve over time and commit
to improving our policies as awareness of social inequities or injustice arise. We believe an equitable and inclusive environment with
diverse teams produces more creative solutions and results in better outcomes for our customers, partners, employees, and stakeholders.
We strive to attract, retain and promote diverse talent at all levels of the organization| |Our management team is 50% female, 25% racially
diverse, and 63% female or racially diverse. The entire Amesite team is 47% female, 40% racially diverse, and 67%
female or racially diverse. Additional information regarding Amesite’s social impact can be found in our 2021 ESG Report available
at www.amesite.io.
Recent
Developments
| ● | Partnering
with the City University of New York (CUNY) to develop and implement professional learning
on a CUNY branded learning portal. CUNY is the largest urban public university
in the U.S., providing learning to over 500,000 learners every year. It is our strong intention
to help them scale their professional offerings – they are exactly the kind of partner
that we seek, to grow revenue and impact for the university and for Amesite. |
| ● | Partnering
with Conner Prairie, a living history museum located in Indiana, to deliver eLearning powered
by a new online ecosystem, with an anticipated launch in 2022. This new Learning
Community EnvironmentSM (LCESM) provides a complete ecosystem
for digital learning, including an eCommerce solution, helping make history come alive for
people all around the world. |
| ● | Extending
our partnership with Wayne State University, the third largest university in Michigan, for
three years. We plan to continue delivering professional certificate programs on Wayne
State University’s LCESM. With a retention rate of over 98%, we are excited
to push ahead with existing and new programs. |
| ● | Expanding
our partnership with the EWIE Company, to provide global dashboards to deliver and track
learning to workers across the globe. With integrations that enable more facile
sharing of data across the enterprise, this LCESM is a model for the future
of industrial learning. |
Liquidity
and Capital Resources
Going
Concern
Our
financial statements are prepared in accordance with U.S. generally accepted accounting principles, or GAAP, applicable to a going concern,
which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business.
We
are in the early stages of developing our customer base and have not completed our efforts to establish a stabilized source of revenue
sufficient to cover our costs over an extended period of time. For the years ended June 30, 2021 and 2020, we had net losses of $11,586,292
and $4,170,303, respectively. For the three and nine month periods ended March 31, 2022, we incurred net losses of $2,216,111 and $6,619,507,
respectively.
The
Company does not have sufficient cash on hand or available liquidity to maintain operations for at least twelve months. These conditions
raise substantial doubt about the Company’s ability to continue as a going concern.
In
response to the conditions, management plans include raising capital through equity financing, or by selling additional shares to Lincoln
Park Capital per the per the purchase agreement we entered into with Lincoln Park Capital in August of 2021 or by completing other offerings
of common stock. However, these plans are subject to market conditions, and are not within the Company’s control, and therefore,
cannot be deemed probable. There is no assurance that the Company will be successful in implementing its business plan, generate sufficient
cash from operations or sell stock on favorable terms or at all. As a result, the Company has concluded that management’s plans
do not alleviate substantial doubt about the Company’s ability to continue as a going concern.
The
financial statements incorporated by reference do not include any adjustments relating to the recoverability and classification of recorded
asset amounts or the amounts and classification of liabilities that might result from the outcome of this uncertainty.
Our
Corporate Information
The
Company was incorporated in November 2017. On September 18, 2020, we consummated a reorganizational merger (the “Reorganization”),
pursuant to an Agreement and Plan of Merger (the “Merger Agreement”), dated July 14, 2020, whereby Amesite Inc. (“Amesite
Parent”), our former parent corporation, merged with and into us, with our Company resulting as the surviving entity. In connection
with the same, we filed a Certificate of Ownership and Merger with the Secretary of State of the State of Delaware, and changed our name
from “Amesite Operating Company” to “Amesite Inc.” The stockholders of Amesite Parent approved the Merger Agreement
on August 4, 2020. The directors and officers of Amesite Parent became our directors and officers.
Pursuant
to the Merger Agreement, on the Effective Date, each share of Amesite Parent’s common stock, $0.0001 par value per share, issued
and outstanding immediately before the Effective Date, was converted, on a one-for-one basis, into shares of our common stock. Additionally,
each option or warrant to acquire shares of Amesite Parent outstanding immediately before the Effective Date was converted into and became
an equivalent option to acquire shares of our common stock, upon the same terms and conditions.
Our
corporate headquarters are located at 607 Shelby Street, Suite 700 PMB 214, Detroit, Michigan 48226, and our telephone number is (734)
876-8130. We maintain a website at www.amesite.com. The contents of, or information accessible through, our website are not part of this
Annual Report on Form 10-K, and our website address is included in this document as an inactive textual reference only. We make our filings
with the SEC, including our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and all amendments
to those reports, available free of charge on our website as soon as reasonably practicable after we file such reports with, or furnish
such reports to, the SEC. The public may read and copy the materials we file with the SEC at the SEC’s Public Reference Room at
100 F Street, NE, Washington, D.C. 20549. The public may also obtain information on the operation of the Public Reference Room by calling
the SEC at 1-800-SEC-0330. Additionally, the SEC maintains an internet site that contains reports, proxy and information statements and
other information. The address of the SEC’s website is www.sec.gov. The information contained in the SEC’s website is not
intended to be a part of this filing.
THE
OFFERING
Common stock offered by us |
|
4,181,821 shares. |
Number of Warrants offered by
us in concurrent private placement |
|
4,181,821 |
|
|
|
Common stock to be outstanding immediately after
the offering (1) |
|
30,175,305 shares (excludes
4,181,821 shares of common stock issuable upon exercise of the Warrants issued in connection with the concurrent private placement). |
|
|
|
Offering price per share |
|
$0.425 per share |
|
|
|
Concurrent Private Placement |
|
In a concurrent private
placement, we are also selling to the purchasers of shares of our common stock in this offering Warrants to purchase an aggregate
of 4,181,821 shares of our common stock. The Warrants issued in the private placement and the shares of our common stock issuable
upon the exercise of the Warrants are not being registered under the Securities Act at this time, are not being offered pursuant
to this prospectus supplement and the accompanying prospectus and are being offered pursuant to the exemption provided in Section
4(a)(2) under the Securities Act and Rule 506(b) promulgated thereunder. |
Use of proceeds |
|
The net proceeds
from our sale of common stock in this offering will be approximately $2.0 million, after deducting placement agent fees and other
estimated offering expenses payable by us and excluding the proceeds from the exercise of the Warrants or placement agent warrants,
if any. We currently expect to use the net proceeds for working capital and for other general corporate purposes. See “Use
of Proceeds.” |
Dividend policy |
|
We have never
paid cash dividends on our common stock and do not anticipate paying any cash dividends in the foreseeable future but intend to retain
our capital resources for reinvestment in our business. |
Risk factors |
|
Investing in
our common stock involves a high degree of risk. You should read the “Risk Factors” section beginning on page S-10
of this prospectus supplement and page 9 of the accompanying prospectus and in the documents incorporated by reference in this prospectus
supplement for a discussion of factors to consider before deciding to invest in our common stock. |
Lock-Up Agreements |
|
We
have agreed that, subject to certain exceptions, without the prior written consent of the placement agent,
we will not, for a period of 75 days following the closing of the offering contemplated by this prospectus
supplement, offer or contract to sell any of our shares of common stock or common stock equivalents.
Our
directors, and executive officers have agreed that, subject to certain exceptions, without the prior written consent of the placement
agent, we and each of our directors and executive officers will not, for a period of 90 days following the closing of the offering
contemplated by this prospectus supplement, offer or contract to sell any of our shares of common stock or common stock equivalents.
See “Plan of Distribution |
Nasdaq Capital Market symbol |
|
“AMST.” |
The
number of shares of common stock to be outstanding immediately after this offering is based on 25,993,484 shares of our common stock
outstanding as of the date hereof, and excludes:
|
● |
1,084,239
shares of common stock issuable upon exercise of warrants with a weighted average exercise price of $1.564; |
|
● |
4,600,000
shares of common stock reserved for future issuance under our 2018 Equity Incentive Plan; |
|
● |
4,181,821 shares of common stock issuable upon exercise of warrants
issued in connection with this offering at an exercise price of $0.82 per share; |
|
● |
187,500 shares of common stock issuable upon exercise of warrants
issued to the representative of the underwriters as part of our February 2022 public offering at an exercise price of $1.00 per share; |
|
● |
150,000
shares of common stock issuable upon exercise of warrants issued to the representative of the underwriters as part of our initial
public offering at an exercise price of $6.00 per share. |
|
● |
209,091 shares of common stock issuable upon exercise of warrants
issued to the placement agent in connection with this offering at an exercise price of $1.025 per
share. |
Except
as otherwise indicated, all information in this prospectus supplement assumes (i) no exercise, conversion, or settlement of the outstanding
options, preferred stock, restricted stock units or warrants described above; and (ii) no exercise of the placement agent’s warrants
to be issued to the placement agent in connection with this offering.
RISK
FACTORS
An
investment in our common stock involves a high degree of risk. Before deciding whether to invest in our common stock, you should consider
carefully the risks described below, together with other information in this prospectus supplement, the accompanying prospectus, the
information and documents incorporated by reference. You should also consider the risks, uncertainties and assumptions discussed under
the heading “Risk Factors” included in our most recent annual report on Form 10-K and the subsequent quarterly reports on
Form 10-Q and other reports that we file with the SEC, which are on file with the SEC and are incorporated herein by reference, and which
may be amended, supplemented or superseded from time to time by other reports we file with the SEC in the future. If any of these risks
actually occurs, our business, financial condition, results of operations or cash flow could be seriously harmed. This could cause the
trading price of our common stock to decline, resulting in a loss of all or part of your investment. The risks and uncertainties described
below are not the only ones facing us. Additional risks and uncertainties not presently known to us, or that we currently see as immaterial,
may also harm our business. Please also read carefully the section below entitled “Special Note Regarding Forward-Looking Statements.”
Going
Concern
There
is substantial doubt about our ability to continue as a going concern.
Our
financial statements are prepared in accordance with U.S. generally accepted accounting principles, or GAAP, applicable to a going concern,
which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. We are in the early
stages of developing our customer base and have not completed our efforts to establish a stabilized source of revenue sufficient to cover
our costs over an extended period of time. For the years ended June 30, 2021 and 2020, we had net losses of $11,586,292 and $4,170,303,
respectively. For the three and nine months ended March 31, 2022, we had net losses of $2,216,111 and $6,619,507, respectively. Our ability
to continue as a going concern is dependent on our ability to raise additional capital and implement our business plan. On February 16,
2022, we completed a public offering of our common stock which resulted in net proceeds to the Company of $2.51 million. In addition,
on August 2, 2021, we entered into a purchase agreement (the “Lincoln Park Purchase Agreement”) with Lincoln Park Capital
Fund, LLC (“Lincoln Park”), under which, subject to specified terms and conditions, we may sell up to $16.5 million of shares
of common stock. We may raise capital by selling additional shares to Lincoln Park, however, the net proceeds under the Lincoln Park
Purchase Agreement will depend on the frequency of sales and the number of shares sold to Lincoln Park and the prices at which we sell
shares to Lincoln Park. Based upon our current operations with our currently available cash balance, management concluded that the current
conditions raise substantial doubt about our ability to continue as a going concern.
We
received a written notice from Nasdaq that we have failed to comply with certain listing requirements of the Nasdaq Stock Market, which
could result in our common stock being delisted from the Nasdaq Stock Market.
On
March 8, 2022, we received a notification from Nasdaq related to our failure to maintain a minimum bid price of $1 per share. Based
on the closing bid price of the Company’s common stock between January 24, 2022 and March 7, 2022, the Company no longer meets
the minimum bid price requirement. However, the Nasdaq Listing Rules also provide us a compliance period of 180 calendar days in
which to regain compliance. Accordingly, if at any time from the date of this notice until September 5, 2022, the closing bid price our
common stock is at least $1 for a minimum of ten consecutive business days, Nasdaq will provide us with written confirmation of compliance
and the matter will be closed. If we do not regain compliance with the minimum bid price requirement by September 5, 2022, we may be
afforded a second 180 calendar day period to regain compliance. To qualify, we would be required to meet all other initial listing standards,
except for the minimum bid price requirement. In addition, we would be required to notify Nasdaq of our intent to cure the deficiency
during the second compliance period. If we do not regain compliance with the minimum bid price requirement by the end of the compliance
period (or the second compliance period, if applicable), our common stock will become subject to delisting. If we are delisted from Nasdaq,
our common stock may be eligible for trading on an over-the-counter market. If we are not able to obtain a listing on another stock exchange
or quotation service for our common stock, it may be extremely difficult or impossible for stockholders to sell their shares. We intend
to monitor the closing bid price of our common stock and may be required to seek approval from our stockholders to affect a reverse stock
split of the issued and outstanding shares of our common stock. However, there can be no assurance that the reverse stock split would
be approved by our stockholders. Further, there can be no assurance that the market price per new share of our common stock after the
reverse stock split will remain unchanged or increase in proportion to the reduction in the number of old shares of our common stock
outstanding before the reverse stock split. Even if the reverse stock split is approved by our stockholders, there can be no assurance
that we will be able to regain compliance with the minimum bid price requirement or will otherwise be in compliance with other Nasdaq
listing rules.
If
we are delisted from Nasdaq, but obtain a substitute listing for our common stock, it will likely be on a market with less liquidity,
and therefore experience potentially more price volatility than experienced on Nasdaq. Stockholders may not be able to sell their shares
of common stock on any such substitute market in the quantities, at the times, or at the prices that could potentially be available on
a more liquid trading market. As a result of these factors, if our common stock is delisted from Nasdaq, the value and liquidity of our
common stock, warrants and pre-funded warrants would likely be significantly adversely affected. A delisting of our common stock from
Nasdaq could also adversely affect our ability to obtain financing for our operations and/or result in a loss of confidence by investors,
employees and/or business partners.
Risks
Related to This Offering1
You
will experience immediate and substantial dilution.
Because
the price per share of common stock being offered in this offering is expected to be substantially higher than the net tangible book
value per share of our common stock, you may experience substantial dilution to the extent of the difference between the effective offering
price per share of common stock you pay in this offering and the net tangible book value per share of our common stock immediately after
this offering. Our net tangible book value as of March 31, 2022, was approximately $8.64 million, or $0.34 per share of common stock.
Net tangible book value per share is equal to our total tangible assets minus total liabilities, all divided by the number of shares
of common stock outstanding. See the section entitled “Dilution” on page S-15 below for a more detailed illustration
of the dilution you may incur if you participate in this offering.
Our
management team may invest or spend the proceeds raised in this offering in ways with which you may not agree or which may not yield
a significant return.
Our
management will have broad discretion over the use of proceeds from this offering. We currently intend to use the net proceeds of this
offering as described in the section entitled “Use of Proceeds.” However, our management will have broad discretion in the
application of the net proceeds from this offering and could use them for purposes other than those contemplated at the time of this
offering. Accordingly, you are relying on the judgment of our management with regard to the use of these net proceeds, and you will not
have the opportunity, as part of your investment decision, to assess whether the proceeds will be used appropriately. The failure by
management to apply these funds effectively could result in financial losses that could have a material adverse effect on our business,
cause the price of our common stock to decline, and delay the development of our product candidates. Pending their use, we may invest
the net proceeds from this offering in short-term, interest-bearing instruments. These investments may not yield a favorable return,
or any return, to us or our stockholders.
Our
stock price is and may continue to be volatile and you may not be able to resell our common stock at or above the price you paid.
The
market price for our common stock is volatile and may fluctuate significantly in response to a number of factors, many of which we cannot
control, such as quarterly fluctuations in financial results, the timing and our ability to advance the development of our product candidates
or changes in securities analysts’ recommendations could cause the price of our stock to fluctuate substantially. Each of these
factors, among others, could harm your investment in our common stock and could result in your being unable to resell the shares of our
common stock that you purchase at a price equal to or above the price you paid.
In
addition, the stock markets in general have experienced extreme volatility that has at times been unrelated to the operating performance
of the issuer. Between February 10, 2021 and August 29, 2022, the closing sales price of our common stock reported on the Nasdaq Capital
Market has ranged between $0.38 and $9.06 per share. These broad market fluctuations may adversely affect the trading price or liquidity
of our common stock. In the past, when the market price of a stock has been volatile, holders of that stock have sometimes instituted
securities class action litigation against the issuer. If any of our stockholders were to bring such a lawsuit against us, we could incur
substantial costs defending the lawsuit and the attention of our management would be diverted from the operation of our business.
We
do not intend to pay dividends on our common stock, so any returns will be limited to the value of our common stock.
We
currently anticipate that we will retain any future earnings to finance the continued development, operation and expansion of our business.
As a result, we do not anticipate declaring or paying any cash dividends or other distributions in the foreseeable future. If we do not
pay dividends, our common stock may be less valuable because stockholders must rely on sales of their common stock after price appreciation,
which may never occur, to realize any gains on their investment.
The
sale of our common stock in this offering and any future sales of our common stock, or the perception that such sales could occur, may
depress our stock price and our ability to raise funds in new stock offerings.
We
may from time to time issue additional shares of common stock at a discount from the current trading price of our common stock. As a
result, our stockholders would experience immediate dilution upon the purchase of any shares of our common stock sold at such discount.
In addition, as opportunities present themselves, we may enter into financing or similar arrangements in the future, including the issuance
of debt securities, preferred stock or common stock. Sales of shares of our common stock in this offering and the public market following
this offering, or the perception that such sales could occur, may lower the market price of our common stock and may make it more difficult
for us to sell equity securities or equity-related securities in the future at a time and price that our management deems acceptable,
or at all.
We
have a short operating history in online programs and may fail to grow our customer base.
We
were incorporated in November 2017, and have a short operating history in offering online courses. Historically, we have had no significant
tangible assets other than cash. If our assumptions about market needs are incorrect, we may fail to launch courses and gain initial
customers. Even if we launch courses in a timely manner, our assumptions regarding recovery of upfront costs and growth of revenue may
differ substantially from reality, in which case we will fail to achieve our revenue goals.
We
have not developed a strong customer base and we have not generated sustainable revenue since inception. There can be no assurance that
we will be able to do so in the future. We will incur significant losses in launching products and we may not realize sufficient subscriptions
or profits in order to sustain our business.
We
have not yet developed a strong customer base and we have not generated sustainable revenue since inception. We are subject to the substantial
risk of failure facing businesses seeking to develop and commercialize new products and technologies. Maintaining and improving our platform
will require significant capital. We also incur substantial accounting, legal and other overhead costs as a public company. If our offerings
to customers are unsuccessful, result in insufficient revenue or result in us not being able to sustain revenue, we will be forced to
reduce expenses, which may result in an inability to gain new customers.
SPECIAL
NOTE REGARDING FORWARD-LOOKING STATEMENTS
This
prospectus supplement, the accompanying prospectus, and the information incorporated by reference in this prospectus supplement contain
“forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities
Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and such forward-looking
statements involve risks and uncertainties. All statements, other than statements of historical facts, contained in this prospectus supplement,
the accompanying prospectus, and the other documents we have filed with the SEC that are incorporated by reference herein, including
statements regarding our strategy, future operations and strategies, future financial position, projected costs, prospects, plans and
objectives of management, are forward-looking statements. Words such as “may,” “should,” “could,”
“would,” “predicts,” “potential,” “continue,” “expects,” “anticipates,”
“future,” “intends,” “plans,” “believes,” “estimates,” “aim,”
“contemplate,” “design,” “might,” “possible,” “project,” “seek,”
“suggest,” “strategy,” “target,” “will,” and similar expressions or phrases or the negative
of those expressions or phrases, as well as statements in future tense, are intended to identify forward-looking statements, although
not all forward-looking statements contain these identifying words. Forward-looking statements should not be read as a guarantee of future
performance or results and may not be accurate indications of when such performance or results will actually be achieved. Forward-looking
statements are based on information we have when those statements are made or our management’s good faith belief as of that time
with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially
from those expressed in or suggested by the forward-looking statements. Important factors that could cause such differences include,
but are not limited to:
|
● |
our
planned online machine learning platform’s ability to enable universities and other clients to offer timely, improved popular
courses and certification programs, without becoming software tech companies; |
|
|
|
|
● |
our
planned online machine learning platform’s ability to result in opportunistic incremental revenue for colleges, universities
and other clients, and improved ability to garner state funds due to increased retention and graduation rates through use of machine
learning and natural language processing; |
|
|
|
|
● |
our
ability to obtain additional funds for our operations; |
|
|
|
|
● |
our
ability to obtain and maintain intellectual property protection for our technologies and our ability to operate our business without
infringing the intellectual property rights of others; |
|
|
|
|
● |
our
reliance on third parties to conduct our business and studies; |
|
● |
our
reliance on third party designers, suppliers, and partners to provide and maintain our learning platform; |
|
|
|
|
● |
our
ability to attract and retain qualified key management and technical personnel; |
|
|
|
|
● |
our
expectations regarding the time during which we will be an emerging growth company under the Jumpstart Our Business Startups Act,
or JOBS Act; |
|
● |
our
financial performance; |
|
|
|
|
● |
the
impact of government regulation and developments relating to our competitors or our industry; and |
|
|
|
|
● |
other
risks and uncertainties, including those listed under the caption “Risk Factors.” |
Although
we believe that we have a reasonable basis for each forward-looking statement contained in this prospectus supplement, the accompanying
prospectus, and the other document documents we have filed with the SEC that are incorporated by reference herein, we caution you that
these statements are based on our projections of the future that are subject to known and unknown risks and uncertainties and other factors
that may cause our actual results, level of activity, performance or achievements expressed or implied by these forward-looking statements,
to differ. We may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements, and you should
not place undue reliance on our forward-looking statements. All forward-looking statements are qualified in their entirety by this cautionary
statement. Forward-looking statements should be regarded solely as our current plans, estimates and beliefs. We have included important
factors in the cautionary statements included in this prospectus supplement, the accompanying prospectus, and the other document documents
we have filed with the SEC that are incorporated by reference herein, particularly in the section entitled “Risk Factors,”
beginning on page S-10 of this prospectus supplement, which we believe could cause our actual results to be materially different from
the plans, intentions and expectations disclosed in the forward-looking statements we make. Moreover, we operate in a very competitive
and rapidly changing environment. New risks emerge from time to time. It is not possible for our management to predict all risks, nor
can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual
results to differ materially from those contained in any forward-looking statements we may make.
Any
forward-looking statement speaks only as to the date on which that statement is made. We assume no obligation to update any forward-looking
statements to reflect events or circumstances after the date of this prospectus supplement, except as may otherwise be required by the
federal securities laws.
USE
OF PROCEEDS
We
expect to receive net proceeds from our sale of common stock in this offering will be approximately $2.0 million, after deducting placement
agent fees and other estimated offering expenses payable by us and excluding the proceeds from the exercise of the Warrants or placement
agent warrants, if any.
We
intend to use the net proceeds from this offering for general corporate purposes, capital expenditures, working capital and general and
administrative expenses. We do not currently have more specific plans or commitments with respect to the net proceeds from this offering
and, accordingly, are unable to quantify the allocation of such proceeds among the various potential issues.
The
expected use of net proceeds of this offering represents our current intentions based upon our present plan and business conditions.
Investors are cautioned, however, that expenditures may vary substantially from these uses. Investors will be relying on the judgment
of our management, who will have broad discretion regarding the application of the proceeds of this offering. The amounts and timing
of our actual expenditures will depend upon numerous factors, including the amount of cash generated by our operations, the amount of
competition we face and other operational factors. We may find it necessary or advisable to use portions of the proceeds from this offering
for other purposes.
Pending
application of the net proceeds as described above, we intend to invest the proceeds to us in investment-grade, interest-bearing securities
such as money market funds, certificates of deposit, or direct or guaranteed obligations of the U.S. government, or hold as cash. We
cannot predict whether the proceeds invested will yield a favorable, or any, return.
DIVIDEND
POLICY
We
have never paid or declared any cash dividends on our common stock, and we do not anticipate paying any cash dividends on our common
stock in the foreseeable future. We intend to retain all available funds and any future earnings to fund the development and expansion
of our business. Any future determination to pay dividends will be at the discretion of our board of directors and will depend upon a
number of factors, including our results of operations, financial condition, future prospects, contractual restrictions, restrictions
imposed by applicable law and other factors our board of directors deems relevant.
DILUTION
If
you invest in our common stock, your interest will be diluted immediately to the extent of the difference between the offering price
per share you will pay in this offering and the as-adjusted net tangible book value per share of our common stock immediately after giving
effect to this offering.
Our
net tangible book value as of March 31, 2022 was approximately $8.64 million, or $0.34 per share of common stock. Net tangible book value
per share is determined by dividing our total tangible assets, less total liabilities, by the number of shares of our common stock outstanding
as of March 31, 2022.
As-adjusted net tangible book
value per share represents our net tangible book value after giving effect to the sale of 4,181,821 shares of common stock at the public
offering price of $0.425 per share, and, after deducting the underwriting discounts and commissions and estimated offering expenses payable
by us in connection with this offering, would have been approximately $10.5 million, or $0.35 per share. This represents an immediate
increase in net tangible book value of $0.015 per share to our existing stockholders and an immediate dilution of approximately $0.074
per share to purchasers of our common stock in this offering.
The
following table illustrates this per share dilution.
Public offering price per share | |
| | | |
$ | 0.425 | |
Net tangible book value per share as of March 31, 2022 | |
$ | 0.336 | | |
| | |
Increase in net tangible book value per share attributable to this offering | |
$ | 0.015 | | |
| | |
As-adjusted net tangible book value per share as of March 31, 2022, after giving effect to this offering | |
| | | |
$ | 0.351 | |
Dilution per share to new investors in this offering | |
| | | |
$ | 0.074 | |
The
above discussion and table are based on 25,739,679 shares of common stock outstanding as of March 31, 2022 and excludes:
|
● |
1,084,239
shares of common stock issuable upon exercise of warrants with a weighted average exercise price of $1.564; |
|
● |
4,600,000
shares of common stock reserved for future issuance under our 2018 Equity Incentive Plan; |
|
● |
4,181,821 shares of common stock issuable upon exercise of warrants issued in connection with this offering at an exercise price of $0.82 per share; |
|
● |
187,500 shares of common stock issuable upon exercise of warrants issued to the representative of the underwriters as part of our February 2022 public offering at an exercise price of $1.00 per share; |
|
● |
150,000 shares of common stock issuable upon exercise of warrants issued to the representative of the underwriters as part of our initial public offering at an exercise price of $6.00 per share; |
|
● |
209,091 shares of common stock issuable upon exercise of warrants issued to the placement agent in connection with this offering at an exercise price of $1.025 per share. |
Except
as otherwise indicated, all information in this prospectus supplement
assumes (i) no exercise, conversion, or settlement of the outstanding options, preferred stock, restricted stock units or warrants described
above; and (ii) no exercise of the placement agent’s warrants to be issued to the placement agent in connection with this offering.
To
the extent that any of these outstanding warrants or options are exercised at prices per share below the public offering price per share
in this offering or we issue additional shares under our equity incentive plans at prices below the public offering price per share in
this offering, you may experience further dilution. In addition, we may choose to raise additional capital due to market conditions or
strategic considerations even if we believe we have sufficient funds for our current or future operating plans. To the extent that we
raise additional capital by issuing equity or convertible debt securities, your ownership will be further diluted.
PRIVATE
PLACEMENT TRANSACTION
Concurrently
with the closing of the sale of shares of common stock in this offering, we also expect to issue and sell to the investors, warrants
to purchase an aggregate of up to 4,181,821 shares of our common stock, or the Warrants, at an initial exercise price equal to $0.82
per share.
The
Warrants and the shares of our common stock issuable upon the exercise of the Warrants are not being registered under the Securities
Act, are not being offered pursuant to this prospectus supplement and the accompanying prospectus and are being offered pursuant to the
exemption provided in Section 4(a)(2) under the Securities Act and Rule 506(b) promulgated thereunder. Accordingly, purchasers may only
sell shares of common stock issued upon exercise of the Warrants pursuant to an effective registration statement under the Securities
Act covering the resale of those shares, an exemption under Rule 144 under the Securities Act or another applicable exemption under the
Securities Act.
Duration
and Exercise Price
The
Warrants offered hereby will have an exercise price of $0.82 per share. The Warrants will be exercisable commencing six months after
the date of issuance for one share of common stock and will expire five and one-half years from the date of issuance. The exercise price
and number of shares of common stock issuable upon exercise are subject to appropriate adjustment in the event of share dividends, share
splits, reorganizations or similar events affecting our shares of common stock. The Warrants will be issued in certificated form
only.
Exercisability
The
Warrants will be exercisable, at the option of each holder, in whole or in part, by delivering to us a duly executed exercise notice
accompanied by payment in full for the number of shares of common stock purchased upon such exercise (except in the case of a cashless
exercise as discussed below). A holder (together with its affiliates) may not exercise any portion of such holder’s Warrants to
the extent that the holder would own more than 4.99% (or, at the election of the purchaser, 9.99%) of our outstanding shares of common
stock immediately after exercise, except that upon at least 61 days’ prior notice from the holder to us, the holder may increase
the amount of ownership of outstanding shares of common stock after exercising the holder’s Warrants up to 9.99% of the number
of shares of common stock outstanding immediately after giving effect to the exercise, as such percentage ownership is determined in
accordance with the terms of the Warrant.
Cashless
Exercise
If
at the time of exercise hereof there is no effective registration statement registering, or the prospectus contained therein is not available
for the issuance of the shares of common stock underlying the Warrants, the Warrants may be exercised on a “cashless exercise”
basis pursuant to which the holder will receive upon such exercise a net number of common stock determined according to a formula set
forth in the Warrants.
Fundamental
Transactions
In
the event of any fundamental transaction, as described in the Warrants and generally including any merger with or into another entity,
sale of all or substantially all of our assets, tender offer or exchange offer, or reclassification of our shares of common stock, then
upon any subsequent exercise of a Warrant, the holder will have the right to receive as alternative consideration, for each share of
common stock that would have been issuable upon such exercise immediately prior to the occurrence of such fundamental transaction, the
number of shares of common stock of the successor or acquiring corporation or of our company, if it is the surviving corporation, and
any additional consideration receivable upon or as a result of such transaction by a holder of the number of shares of common stock for
which the Warrant is exercisable immediately prior to such event.
Trading
Market
There
is no established trading market for the Warrants, and we do not expect a market to develop. We do not intend to apply for a listing
for the Warrants on any securities exchange or other nationally recognized trading system. Without an active trading market, the liquidity
of the Warrants will be limited.
Rights
as a Shareholder
Except
as otherwise provided in the Warrants or by virtue of the holders’ ownership of shares of common stock, the holders of Warrants
will not have the rights or privileges of holders of our shares of common stock, including any voting rights, until such Warrant holders
exercise their Warrants.
PLAN OF DISTRIBUTION
Laidlaw & Company
(UK) Ltd. is acting as placement agent in connection with this offering. The placement agent is not purchasing or selling any of the shares
of common stock offered by this prospectus supplement, but will use its reasonable best efforts to arrange for the sale of the securities
offered by this prospectus supplement. We have entered into a securities purchase agreement directly with the investors in connection
with this offering.
The securities purchase agreement
contains customary representations, warranties and covenants. The offering is expected to close on or about September 1, 2022, subject
to customary closing conditions. Laidlaw & Company (UK) Ltd. is also acting as placement agent for the private placement transaction
and is being paid a fee related to the placement of the Warrants.
This is a brief summary of
the material provisions of the securities purchase agreement and does not purport to be a complete statement of its terms and
conditions. A copy of the form of the securities purchase agreement with the investors is included as an exhibit to a Current Report on
Form 8-K to be filed by the Company with the SEC in connection with this offering and is incorporated by reference into the registration
statement of which this prospectus supplement is part.
Fees and Expenses
We have agreed to pay the placement
agent a fee equal to 8.0% and a cash management fee equal to 1% of the gross proceeds from the common stock sold in this offering sold
by the placement agent.
The following table shows the
per share of common stock and total fees we will pay to the placement agent in connection with the sale of the common stock offered pursuant
to this prospectus supplement and the accompanying prospectus.
| |
Per Share | | |
Total | |
Offering price | |
$ | 0.55 | | |
$ | 2,300,001 | |
Placement agent fees (1)(2) | |
$ | 0.044 | | |
$ | 184,000 | |
Proceeds, before expenses, to us | |
$ | 0.506 | | |
$ | 2,116,001 | |
(1) |
In addition to the
placement agent’s fees of 8.0% of the public offering price, we have agreed to pay the placement agent a cash management fee
of 1% of the gross proceeds from the sales of common stock sold in the offering, and to reimburse the placement agent for certain
out-of-pocket expenses incurred in connection with this offering, including, among other things, the reasonable fees and
disbursements of counsel for the placement agent, in an amount not greater than $100,000. In addition, we have agreed to issue the
placement agent or its designees warrants to purchase a number of shares of common stock equal to 5% of the shares of common stock
sold in this offering. |
We estimate that the total
expenses of the offering and the concurrent private placement, payable by us, not including the placement agent’s fees of approximately
$207,000, in the aggregate, will be approximately $250,000.
Indemnification
We have agreed to indemnify
the placement agent and other specified persons against certain civil liabilities, including liabilities under the Securities Act and
the Exchange Act, and to contribute to payments that the placement agent may be required to make in respect of such liabilities.
Lock-Ups
We have agreed that, subject
to certain exceptions, without the prior written consent of the placement agent, we will not, for a period of 75 days following the
closing of the offering contemplated by this prospectus supplement, offer or contract to sell any of our shares of common stock or common
stock equivalents.
Our directors, and executive
officers have agreed that, subject to certain exceptions, without the prior written consent of the placement agent, we and each of our
directors and executive officers will not, for a period of 90 days following the closing of the offering contemplated by this prospectus
supplement, offer or contract to sell any of our shares of Common Stock or Common Stock equivalents.
Placement Agent Warrants
In addition, we have agreed
to issue to the placement agent (or its designees) warrants (the “Placement Agent Warrants”) to purchase up to 209,091 shares
of common stock, which represents 5% of the aggregate number of shares of common stock sold in this offering. The Placement Agent Warrants
will generally have the same terms as the Warrants except that the Placement Agent Warrants will have an exercise price of $1.025 per
share, which represents 125% of the offering price per share sold in this offering. The Placement Agent’s Warrant may be purchased
in cash or via cashless exercise, shall be exercisable for a period of five years from the closing date of this offering and will terminate
on the fifth anniversary of the closing of this offering, and the Placement Agent Warrants will not be registered hereunder. The Placement
Agent’s Warrant and the shares of common stock issuable upon exercise of the Placement Agent’s Warrant will be deemed compensation
by FINRA, and therefore will be subject to FINRA Rule 5110(e)(1). In accordance with FINRA Rule 5110(e)(1), neither the Placement Agent’s
Warrant nor any of the shares of common stock issued upon exercise of the Placement Agent’s Warrant may be sold, transferred, assigned,
pledged or hypothecated, or be the subject of any hedging, short sale, derivative, put or call transaction that would result in the effective
economic disposition of such securities by any person, for a period of 180 days beginning on the date of commencement of sales of the
public equity offering.
Other Relationships
The placement agent or its
affiliates may in the future engage in transactions with, and may perform, from time to time, investment banking and advisory services
for us in the ordinary course of their business and for which it would receive customary fees and expenses. In addition, in the ordinary
course of its business activities, the placement agent and its affiliates may make or hold a broad array of investments and actively trade
debt and equity securities (or related derivative securities) and financial instruments (including bank loans) for their own account and
for the accounts of its customers. Such investments and securities activities may involve securities and/or instruments of ours or our
affiliates.
Except as disclosed in this
prospectus supplement, we have no present arrangements with the placement agent for any further services.
Trading Market
Our common stock is traded
on The Nasdaq Capital Market under the symbol “AMST.”
LEGAL MATTERS
The validity of the
shares of common stock offered by this prospectus supplement and the accompanying prospectus will be passed upon for us by Sheppard,
Mullin, Richter & Hampton LLP, New York, New York. Sichenzia Ross Ference LLP, New York, New York, is acting as counsel for the
placement agent in connection with the shares of common stock offered hereby.
EXPERTS
The
financial statements of Amesite Inc. incorporated by reference in this Prospectus Supplement by reference to Amesite Inc.’s annual
report on Form 10-K for the year ended June 30, 2021, have been audited by Deloitte & Touche LLP, an independent registered public
accounting firm, as stated in their report. Such financial statements are incorporated by reference in reliance upon the report of such
firm given upon their authority as experts in accounting and auditing.
WHERE YOU CAN FIND MORE INFORMATION
We have filed with the SEC
a registration statement on Form S-3 under the Securities Act, of which this prospectus supplement forms a part. The rules and regulations
of the SEC allow us to omit from this prospectus supplement and the accompanying prospectus certain information included in the registration
statement. For further information about us and the securities we are offering under this prospectus supplement, you should refer to the
registration statement and the exhibits and schedules filed with the registration statement. With respect to the statements contained
in this prospectus supplement and the accompanying prospectus regarding the contents of any agreement or any other document, in each instance,
the statement is qualified in all respects by the complete text of the agreement or document, a copy of which has been filed as an exhibit
to the registration statement.
We file reports,
proxy statements and other information with the SEC. The SEC maintains a website that contains reports, proxy and information statements
and other information regarding issuers that file electronically with the SEC. The address of the SEC’s website is www.sec.gov.
We make available
free of charge on or through our website at www.amesite.com, our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports
on Form 8-K and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act, as soon as reasonably
practicable after we electronically file such material with or otherwise furnish it to the SEC. The information on, or accessible through,
our website is not part of, and is not incorporated into, this prospectus supplement or the accompanying prospectus and should not be
considered part of this prospectus supplement or the accompanying prospectus.
INFORMATION INCORPORATED BY REFERENCE
The SEC’s rules allow
us to “incorporate by reference” information into this prospectus supplement, which means that we can disclose important information
to you by referring you to another document filed separately with the SEC. The information incorporated by reference is deemed to be part
of this prospectus supplement and the accompanying prospectus, and subsequent information that we file with the SEC will automatically
update and supersede that information. Any statement contained in a previously filed document incorporated by reference will be deemed
to be modified or superseded for purposes of this prospectus supplement and accompanying prospectus to the extent that a statement contained
in this prospectus supplement or the accompanying prospectus modifies or replaces that statement.
We incorporate by reference
our documents listed below and any future filings made by us with the SEC under Sections 13(a), 13(c), 14 or 15(d) of the Exchange
Act in this prospectus supplement, between the date of this prospectus supplement and the termination of the offering of the securities
described in this prospectus supplement. We are not, however, incorporating by reference any documents or portions thereof, whether specifically
listed below or filed in the future, that are not deemed “filed” with the SEC, including our Compensation Committee report
and performance graph or any information furnished pursuant to Items 2.02 or 7.01 of Form 8-K or related exhibits furnished
pursuant to Item 9.01 of Form 8-K, unless such Form 8-K expressly provides to the contrary.
This prospectus supplement
and the accompanying prospectus incorporate by reference the documents set forth below that have previously been filed with the SEC:
| ● | our
Annual Report on Form 10-K for the fiscal year ended June 30, 2021, filed with the SEC on September 10, 2021, as amended by Amendment
No. 1 to our Annual Report on Form 10-K/A filed with the SEC on March 9, 2022; |
| ● | our
Quarterly Report on Form 10-Q for the quarter ended September 30, 2021, filed on November 15, 2021; |
| ● | our
Quarterly Report on Form 10-Q for the quarter ended December 31, 2021, filed on February 18, 2022; |
| ● | our
Quarterly Report on Form 10-Q for the quarter ended March 31, 2022, filed on May 13, 2022; |
| ● | the
description of the Company’s common stock and warrants contained in the Form 8-A filed with the SEC on September 23, 2020, including
any amendments thereto or reports filed for the purposes of updating this description. |
All reports and other documents
we subsequently file pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act prior to the termination of this offering,
including, but excluding any information furnished to, rather than filed with, the SEC, will also be incorporated by reference into this
prospectus supplement and the accompanying prospectus and deemed to be part of this prospectus supplement and the accompanying prospectus
from the date of the filing of such reports and documents.
You should rely only on the
information incorporated by reference or provided in this prospectus. We have not authorized anyone else to provide you with different
information. You should not assume that the information in this prospectus supplement is accurate as of any date other than the date of
this prospectus supplement or the date of the documents incorporated by reference in this prospectus supplement.
You may request a free copy
of any of the documents incorporated by reference in this prospectus supplement and the accompanying prospectus (other than exhibits,
unless they are specifically incorporated by reference in the documents) by writing or telephoning us at the following address:
Amesite Inc.
Attn: Chief Executive Officer
607 Shelby Street
Suite 700 PMB 214
Detroit, MI 48226
(734) 876-8130
You may also access the
documents incorporated by reference in this prospectus through our website at www.amesite.com. Except for the specific incorporated documents
listed above, no information available on or through our website shall be deemed to be incorporated in this prospectus or the registration
statement of which it forms a part.
Prospectus
Amesite Inc.
Common Stock
Preferred Stock
Debt Securities
Warrants
Rights
Units
We may offer and sell, from
time to time in one or more offerings, any combination of common stock, preferred stock, debt securities, warrants to purchase common
stock, preferred stock or debt securities, rights, or any combination of the foregoing, either individually or as units comprised of one
or more of the other securities, having an aggregate initial offering price not exceeding $100,000,000.
This prospectus provides a
general description of the securities we may offer. Each time we sell a particular class or series of securities, we will provide the
specific terms of the securities offered in a supplement to this prospectus. The prospectus supplement and any related free writing prospectus
may also add, update or change information contained in this prospectus. We may also authorize one or more free writing prospectuses to
be provided to you in connection with these offerings. You should read carefully this prospectus, the applicable prospectus supplement
and any related free writing prospectus, as well as any documents incorporated by reference herein or therein before you invest in any
of our securities.
The specific terms of any
securities to be offered, and the specific manner in which they may be offered, will be described in one or more supplements to this prospectus.
This prospectus may not be used to consummate sales of any of these securities unless it is accompanied by a prospectus supplement. Before
investing, you should carefully read this prospectus and any related prospectus supplement.
Our common stock is presently
listed on The Nasdaq Capital Market under the symbol “AMST.” On October 29, 2021, the last reported sale price of our common
stock was $1.65 per share. The applicable prospectus supplement will contain information, where applicable, as to any other listing on
The Nasdaq Capital Market or any securities market or other exchange of the securities, if any, covered by the prospectus supplement.
Prospective purchasers of our securities are urged to obtain current information as to the market prices of our securities, where applicable.
These securities may be sold
directly by us, through dealers or agents designated from time to time, to or through underwriters, dealers, or through a combination
of these methods on a continuous or delayed basis. See “Plan of Distribution” in this prospectus. We may also describe
the plan of distribution for any particular offering of our securities in a prospectus supplement. If any agents, underwriters or dealers
are involved in the sale of any securities in respect of which this prospectus is being delivered, we will disclose their names and the
nature of our arrangements with them in a prospectus supplement. The price to the public of such securities and the net proceeds we expect
to receive from any such sale will also be included in a prospectus supplement.
Investing in our securities
involves various risks. See “Risk Factors” beginning on page 9 for more information on these risks. Additional
risks will be described in the related prospectus supplements under the heading “Risk Factors.” You should review
that section of the related prospectus supplements for a discussion of matters that investors in our securities should consider.
Neither the U.S. Securities
and Exchange Commission nor any state securities commission has approved or disapproved of these securities, or passed upon the adequacy
or accuracy of this prospectus or any accompanying prospectus supplement. Any representation to the contrary is a criminal offense.
The date of this prospectus is , 2021.
TABLE OF CONTENTS
ABOUT THIS PROSPECTUS
This prospectus is part of
a registration statement that we filed with the U.S. Securities and Exchange Commission, or SEC, using a “shelf” registration
process. Under this shelf registration statement, we may sell from time to time in one or more offerings of common stock and preferred
stock, various series of debt securities and/or warrants to purchase any of such securities, and rights, either individually or as units
comprised of a combination of one or more of the other securities in one or more offerings up to a total dollar amount of $100,000,000.
This prospectus provides you with a general description of the securities we may offer. Each time we sell any type or series of securities
under this prospectus, we will provide a prospectus supplement that will contain more specific information about the terms of that offering.
This prospectus does not contain
all of the information included in the registration statement. For a more complete understanding of the offering of the securities, you
should refer to the registration statement, including its exhibits. We may add, update or change in a prospectus supplement or free writing
prospectus any of the information contained in this prospectus or in the documents we have incorporated by reference into this prospectus.
We may also authorize one or more free writing prospectuses to be provided to you that may contain material information relating to these
offerings. This prospectus, together with the applicable prospectus supplement, any related free writing prospectus and the documents
incorporated by reference into this prospectus and the applicable prospectus supplement, will include all material information relating
to the applicable offering. You should carefully read both this prospectus and the applicable prospectus supplement and any related free
writing prospectus, together with the additional information described under “Where You Can Find More Information,”
before buying any of the securities being offered.
We have not authorized any
dealer, agent or other person to give any information or to make any representation other than those contained or incorporated by reference
in this prospectus, any accompanying prospectus supplement or any related free writing prospectus that we may authorize to be provided
to you. You must not rely upon any information or representation not contained or incorporated by reference in this prospectus or an accompanying
prospectus supplement, or any related free writing prospectus that we may authorize to be provided to you. This prospectus, the accompanying
prospectus supplement and any related free writing prospectus, if any, do not constitute an offer to sell or the solicitation of an offer
to buy any securities other than the registered securities to which they relate, nor do this prospectus, the accompanying prospectus supplement
or any related free writing prospectus, if any, constitute an offer to sell or the solicitation of an offer to buy securities in any jurisdiction
to any person to whom it is unlawful to make such offer or solicitation in such jurisdiction. You should not assume that the information
contained in this prospectus, any applicable prospectus supplement or any related free writing prospectus is accurate on any date subsequent
to the date set forth on the front of the document or that any information we have incorporated by reference is correct on any date subsequent
to the date of the document incorporated by reference (as our business, financial condition, results of operations and prospects may have
changed since that date), even though this prospectus, any applicable prospectus supplement or any related free writing prospectus is
delivered or securities are sold on a later date.
We further note that the representations,
warranties and covenants made by us in any agreement that is filed as an exhibit to any document that is incorporated by reference in
this prospectus were made solely for the benefit of the parties to such agreement, including, in some cases, for the purpose of allocating
risk among the parties to such agreements, and should not be deemed to be a representation, warranty or covenant to you. Moreover, such
representations, warranties or covenants were accurate only as of the date when made. Accordingly, such representations, warranties and
covenants should not be relied on as accurately representing the current state of our affairs.
This prospectus may not be
used to consummate sales of our securities, unless it is accompanied by a prospectus supplement. To the extent there are inconsistencies
between any prospectus supplement, this prospectus and any documents incorporated by reference, the document with the most recent date
will control.
As permitted by the rules
and regulations of the SEC, the registration statement, of which this prospectus forms a part, includes additional information not
contained in this prospectus. You may read the registration statement and the other reports we file with the SEC at the SEC’s web
site or at the SEC’s offices described below under the heading “Where You Can Find More Information.”
Company References
In this prospectus “the
Company,” “we,” “us,” and “our” refer to Amesite Inc., a Delaware corporation, and its
subsidiaries, unless the context otherwise requires.
OUR BUSINESS
Overview
Amesite’s smart, intuitive
learning environments help organizations thrive. Amesite is a high tech artificial intelligence software company offering a cloud-based
platform and content creation services for business and university-delivered education and upskilling. Amesite-offered courses and programs
are branded to our customers. Amesite uses artificial intelligence technologies to provide customized environments for learners, easy-to-manage
interfaces for instructors, and greater accessibility for learners in the US education market and beyond. The Company leverages existing
institutional infrastructures, adding mass customization and cutting-edge technology to provide cost-effective, scalable and engaging
experiences for learners anywhere.
Businesses need learning and
development (L&D) platforms to upskill workers, to improve retention and enable them to achieve their goals.
We are passionate about improving
the learner experience and learner outcomes in online learning products, and improving our customers’ ability to create and deliver
both. We are focused on creating the best possible technology solutions and have been awarded an innovation award for our product. We
are committed to our team, and have twice been recognized with national workplace excellence awards.
Our Strategy
We
deliver Learning Community Environments (LCEs) to businesses and educational institutions (EIs) that enable them to offer branded learning
products to their employees or students with ease. Our business model offers flexibility for our customers. Our customers license our
platform and can also contract with to us to create and maintain customized learning products, or easily launch their own learning products
on the platform. We have entered into master service agreements with our customers, including, but not limited to, universities such as
Wayne State University and enterprises such as The Henry Ford. These agreements include statements of work detailing the services to be
rendered and programs or products to be delivered on the platform. We use the proprietary data we collect on learner behavior and responses
with their consent, to deliver to learners engaging, effective courses and programs. Our customers gain efficiency, flexibility and can
generate high return on investment and revenue through partnership with us, because of the speed, flexibility, effectiveness and scalability
of the LCEs we build for them.
Businesses
need learning systems that enable them to upskill people quickly and efficiently. Retention and execution of strategic plans require that
employees stay engaged, and learn effectively. Universities need to be able to launch programs that upskill their alumni and other professionals,
accessibly and scalably. Government needs to be able to offer learning programs that allow job seekers to advance skills. Amesite’s
cloud-based platform addresses all of these key needs.
Our Proprietary Technology
We
believe that online learning products are essential for accessibility, engagement and scalability for businesses and EIs alike. We utilize
artificial intelligence to achieve improved engagement, and continuous integration of current, qualified information into our learning
products.
Our
technology utilizes a flexible and scalable full stack solution, with robust tools powering front-end technology. Our code architecture
offers outstanding accessibility and agility for engineers, using best-in-class languages for both client and server-side functions. We
also use tools employed by many high-end platforms. Our architecture enables us to achieve full integration of best-in-class third party
tools, and custom-built features, delivering on-demand and as-needed, such as leading calendar platform integrations, and high quality,
encrypted video calling.
Our
architecture enables us to utilize artificial intelligence algorithms to ultimately improve learning outcomes. Much as artificial
intelligence algorithms presently recognize and respond to natural language on commercial platforms, predict behaviors and deliver suggestions,
our algorithms have been developed to assist learners in accessing, utilizing and remaining engaged with platform content, their instructors
and their peers.
We
generate content for our customers using the highest standards in business and higher education, and our business model enables us to
deliver content for our customers efficiently and rapidly. Rapidly evolving technology has driven the need to continuously upskill
students and workforces, and we use the highest possible standards to deliver this content according to customer needs. This substantially
reduces the time it takes for traditional program creation by businesses or EIs.
We
market to our customers, and enable them to offer and monetize learning products, or to deliver learning products to their own employees
efficiently and cost effectively. Our customers want the capability of delivery to their own customers, and are best able to
market to them. We deliver the content and technology to enable this.
We
protect and utilize learner data solely to improve learning outcomes. Learner data is collected with learner permission, and
information about learner behavior, study preferences and preference for types of material delivered as part of learning products, will
be used to improve learning outcomes and learner experiences. We will validate algorithms using both offline and online testing. By correlating
learner behaviors with specific outcomes as identified by qualified instructors, we will train our algorithms specifically for important
learning outcomes, enabling it to be a useful tool for instructors. We believe that the combinations of information that will be collected
through our educational products, and outcomes measured using our online learning products will be unique, and constantly improving. We
will never sell or distribute our learner data to third parties without the explicit permission of learners. We will not deliver unwanted
content or advertising to learners or to customer personnel. Our proprietary technology is developed solely for purposes of improving
learner experiences and outcomes, and improving the ability of our customers to deliver outstanding educational products.
Our Research and Development
Programs
We
use advanced technologies to create effective and accessible learning environments. We seek to improve learning at many levels, including
college and professional. Our research and development programs will expand continuously based on learner preferences, outcomes and the
desires of our customers. Some of these will include:
| ● | Improvements
in learner engagement with cloud-based platforms. We will continuously gather data on how learners engage with us and other online
platforms, and conduct research and development to create and incorporate useful tools for learning on our platform. |
| ● | Improvements
in instructor experience using our platform. We will continuously develop tools designed to improve the ability of our customers
to deliver timely and relevant content, deliver assessments which are fair, correctly represent educational objectives and give repeatable
outcomes when employed on our platform. |
| ● | Integration
of new technology in the delivery of learning products. A “technology stack” is a combination of software products and
programming languages used to create our platform. We will continuously develop improvements to our technology stack, inventing and integrating
best-in-class online engagement features. These will range from invention of novel user experience features, to integration of capabilities
offered by other vendors and developers. |
| ● | Qualification
of information for use by learners in all sectors. We plan to provide both our customers and our learners with the constantly improving
ability to find and integrate qualified information into products on our platform, and maximize learner ability to utilize qualified
information, designed to offer learners the most carefully curated, most relevant, timely and engaging materials in every discipline
in which we offer products. |
Our Intellectual Property
Our
intellectual property rights include patent applications, trade secrets, trademark rights, and contractual agreements. Our patent applications
are directed to our proprietary technology, including an artificial intelligence platform for learning, and will seek patent protection
for our designs, development, and related alternatives by filing and prosecuting patent applications in the U.S. and other countries as
appropriate.
We’ve
received two U.S. patents and currently have five pending U.S. patent applications, including one to cover the artificial intelligence
platform, and others related to security, power consumption, blockchain, design and other technologies, including methods and systems.
Any patent issued from these applications are expected to expire in 2038, not including any applicable patent term adjustment or extension
or design patents.
We
have protected our source codes, methodologies, algorithms, and techniques directed to other aspects of our artificial intelligence learning
platform using our trade secret rights. We have received trademarks for AMESITETM, LEARNING COMMUNITY ENVIRONMENTTM and
KEEP LEARNINGTM from the United States Patent and Trademark Office. We have also secured domain names, including amesite.com,
amesite.co, amesite.net, and others.
We
ensure that we own intellectual property created for us by signing agreements with employees, independent contractors, consultants, companies,
and any other third party that creates intellectual property for us or that assign any intellectual property rights to us. Portions of
our platform may rely upon third-party licensed intellectual property.
We
have established business procedures designed to maintain the confidentiality of our proprietary information, including the use of confidentiality
agreements with employees, independent contractors, consultants and entities with which we conduct business.
Competition
The
online and software industries for higher education are characterized by rapid evolution of technologies, fierce competition, government
regulation, and strong defense of intellectual property. The overall market for technology solutions that enable providers to deliver
education online is highly fragmented, rapidly evolving and subject to changing technology, shifting needs of learners and educators and
frequent introductions of new methods of delivering education online. While we believe that our platform, programs, technology, knowledge,
experience, and resources provide us with competitive advantages, we face competition from major online companies, academic institutions,
governmental agencies, and public and private research institutions, among others.
Any
learning product that we successfully develop and commercialize will compete with current learning products. Key product features that
would affect our ability to effectively compete with other course offerings include efficiency, security and convenience, and availability.
Our competitors fall primarily into the following groups:
| ● | Online
Program Management (OPM) firms, who create and launch educational products for EIs and businesses, using either their own or others’
Learning Management Systems (LMSs). |
| ● | Learning
Management System (LMS) technology firms, who offer technology platforms suitable for offering online educational or training products |
| ● | Learning
product aggregators, who offer multiple ‘institutions or businesses’ learning products on online platforms for direct purchase
by learners, or through licenses by institutions. |
Many
of the companies, colleges, or universities against which we may compete have significantly greater financial resources and expertise
in education, software design and development, and have already obtained approvals and marketing approved products. Smaller or early-stage
companies may also prove to be significant competitors, particularly through collaborative arrangements with large and established companies.
These competitors also compete with us in recruiting and retaining qualified engineers, scientists, and management personnel, as well
as in acquiring technologies complementary to, or necessary for, our programs.
We
expect that the competitive landscape will continue to expand as the market for online programs at nonprofit institutions matures. We
believe the principal competitive factors in our market include the following:
| ● | brand
awareness and reputation; |
| ● | ability
of online programs to deliver desired learner outcomes; |
| ● | robustness
and evolution of technology offering; and |
| ● | breadth
and depth of service offering. |
We
believe we compete favorably on the basis of these factors. Our ability to remain competitive will depend, to a great extent, on our ability
to consistently deliver high-quality offerings; meet client needs for content development; attract, support and retain learners; and deliver
desired outcomes for our customers and their learners.
Government Regulation
and Product Approval
The
education industry is heavily regulated. Institutions of higher education that award degrees and certificates to signify the successful
completion of an academic program are subject to regulation from three primary entities, namely, the U.S. Department of Education (the
“DOE”), accrediting agencies, and state licensing authorities. Each of these entities promulgates and enforces its own laws,
regulations and standards, which we refer to collectively as education laws.
We
contract with higher education institutions that are subject to education laws. In addition, we are required to comply with certain education
laws as a result of our role as a service provider to institutions of higher education, either directly or indirectly through our contractual
arrangements with customers. Our failure, or that of our customers, to comply with education laws could adversely impact our operations.
As a result, we work closely with our customers to maintain compliance with education laws.
We
will abide by education laws, including incentive compensation rules, misrepresentation rules, accreditation rules and standards, among
state and federal regulations. We also closely monitor state law developments and we will work closely with our customers to assist them
with obtaining any required approvals.
Our
activities on behalf of our customers are also subject to other federal and state laws. These regulations include, but are not limited
to, consumer marketing and unfair trade practices laws and regulations, including those promulgated and enforced by the Federal Trade
Commission, as well as federal and state data protection and privacy requirements.
Sales and Marketing
We
plan to grow our sales and marketing program as we build our customer base, advancing from our small, direct sales force to a distribution
network that has existing relationships with colleges, universities, non-profit organizations and businesses.
We
also intend to develop a branding strategy to introduce and support our platform. The strategy may include our presence at colleges, universities,
and other commercial institutions on a national, state, and regional basis to engage and educate users of our products, as well as engaging
in a variety of other direct marketing methods to educational institutions and businesses. We plan to pursue selected business opportunities,
including joint developments, collaborations and acquisitions that have the potential to build sales more rapidly. We aim to develop and
pursue such opportunities on a consistent basis to grow the Company.
Board of Advisors
Dennis Bernard, Chairman
of the Board of Advisors
Mr.
Bernard is the founder and President of Bernard Financial Group and Bernard Financial Servicing Group (“BFG”). BFG is the
largest commercial mortgage banking firm in Michigan, financing, on average, over $1.0 billion annually. Mr. Bernard has been involved
with over 1,200 commercial real estate financial transactions totaling over $18.6 billion. Mr. Bernard specializes in both debt and equity
placement with commercial lenders and institutional joint venture participants.
Martha A. Darling,
Member
Over
the past 22 years, Ms. Darling has held volunteer leadership roles nationally and in Michigan and has consulted on education policy issues
for the National Academy of Sciences and other non-profit organizations. Prior to moving to Ann Arbor, Ms. Darling was a Senior Program
Manager at The Boeing Company in Seattle, from which she retired in 1998. She joined Boeing in 1987, with assignments in 747 Program Management,
Government Affairs and Boeing’s Corporate Offices, where she supported the chief executive officer and other executives. Previously,
she was Vice President for Strategic Planning at Seattle-First National Bank and then, on loan from Seattle-First, she served as Executive
Director of the Washington Business Roundtable’s Education Study. From 1977 to 1982 she served in Washington, D.C. as White House
Fellow and Executive Assistant to Secretary of the Treasury W. Michael Blumenthal and then as Senior Legislative Aide to U.S. Senator
Bill Bradley. She has also served as Special Assistant to the Governor of Washington, Research Social Scientist at the Battelle Seattle
Research Center, and was a free-lance consultant to the Organization for Economic Cooperation and Development and other international
organizations for four years in Paris.
Theodore l. Spencer,
Member
Mr.
Spencer is Senior Advisor on Admissions Outreach at the University of Michigan. Prior to September 2014, he was Associate Vice Provost
and Executive Director of Undergraduate Admissions. Before joining Michigan in 1989, he was an Associate Director of Admissions at the
United States Air Force Academy. He is a graduate of the Military Air War College and was one of thirty-five Air Force recruiting commanders
in the United States. He is a retired Lieutenant Colonel in the United States Air Force. Early in his career, he was a salesman for the
IBM Corporation in the City of Detroit. Ted has presented at numerous professional conferences state-wide, nationally and internationally,
and has written and published articles on the college admissions process. He has received numerous awards, and was recognized as the Point
Man on Diversity Defense for affirmative action in college admissions. He has previously served as a Trustee for the College Board and
on the faculty for the Harvard Summer Institute on College Admissions. Ted holds a M.S. degree in sociology from Pepperdine University
and a B.S. in political science from Tennessee State University.
Human Capital Management
General Information
About Our Human Capital Resources
As
of September 8, 2021, we have 26 total employees, comprised of 22 full-time employees and 4 consultants. We intend to hire additional
staff and to engage consultants in general administration on an as-needed basis. We also intend to engage experts in operations, finance
and general business to advise us in various capacities. None of our employees are covered by a collective bargaining agreement, and we
believe our relationship with our employees is good to excellent.
Our Culture
Amesite’s
mission is to improve the way the world learns. We are passionate about understanding the needs of our learners, and we work hard to build
products that deliver—for each and every one. We also believe that supporting our team with a wonderful environment supports and
powers us to accomplish our goals. Our values are summarized in our beats—the guideposts for our culture.
| ● | Measurement
beats conjecture |
| ● | Humility
beats arrogance |
| ● | Honesty
beats politeness |
| ● | Transparency
beats manipulation |
| ● | Passion
beats indifference |
Diversity and Inclusion
To
truly change how the world learns and improve the learning process and environment for learners across the world, we need to work with
a diversity of partners as well as have a diverse workforce. We also must operate with a high degree of awareness of evolving social conditions,
social justice – and create policy accordingly. We acknowledge that these measures evolve over time and commit to improving
our policies as awareness of social inequities or injustice arise. We believe an equitable and inclusive environment with diverse teams
produces more creative solutions and results in better outcomes for our customers, partners, employees, and stakeholders. We strive to
attract, retain and promote diverse talent at all levels of the organization. Our management team is 29% female, 21% racially diverse,
and 43% female or racially diverse. The entire Amesite team is 46% female, 21% racially diverse, and 54% female or racially diverse. Additional
information regarding Amesite’s social impact can be found in our 2021 ESG Report available at www.amesite.com.
The Securities We May Offer
We may offer shares of our
common stock and preferred stock, various series of debt securities and warrants or rights to purchase any of such securities, either
individually or in units, from time to time under this prospectus, together with any applicable prospectus supplement and related free
writing prospectus, at prices and on terms to be determined by market conditions at the time of offering. If we issue any debt securities
at a discount from their original stated principal amount, then, for purposes of calculating the total dollar amount of all securities
issued under this prospectus, we will treat the initial offering price of the debt securities as the total original principal amount of
the debt securities. Each time we offer securities under this prospectus, we will provide offerees with a prospectus supplement that will
describe the specific amounts, prices and other important terms of the securities being offered, including, to the extent applicable:
| ● | designation
or classification; |
| ● | aggregate
principal amount or aggregate offering price; |
| ● | maturity,
if applicable; |
| ● | original
issue discount, if any; |
| ● | rates
and times of payment of interest or dividends, if any; |
| ● | redemption,
conversion, exchange or sinking fund terms, if any; |
| ● | conversion
or exchange prices or rates, if any, and, if applicable, any provisions for changes to or adjustments in the conversion or exchange prices
or rates and in the securities or other property receivable upon conversion or exchange; |
| ● | restrictive
covenants, if any; |
| ● | voting
or other rights, if any; and |
| ● | important
United States federal income tax considerations. |
A prospectus supplement and
any related free writing prospectus that we may authorize to be provided to you may also add, update, or change information contained
in this prospectus or in documents we have incorporated by reference. However, no prospectus supplement or free writing prospectus will
offer a security that is not registered and described in this prospectus at the time of the effectiveness of the registration statement
of which this prospectus is a part.
We may sell the securities
to or through underwriters, dealers or agents or directly to purchasers. We, as well as any agents acting on our behalf, reserve the sole
right to accept and to reject in whole or in part any proposed purchase of securities. Each prospectus supplement will set forth the names
of any underwriters, dealers or agents involved in the sale of securities described in that prospectus supplement and any applicable fee,
commission or discount arrangements with them, details regarding any over-allotment option granted to them, and net proceeds to us. The
following is a summary of the securities we may offer with this prospectus.
Common Stock
We currently have authorized
100,000,000 shares of common stock, par value $0.0001 per share. As of June 30, 2021, 20,571,682 shares of common stock were issued and
outstanding. We may offer shares of our common stock either alone or underlying other registered securities convertible into or exercisable
for our common stock. Holders of our common stock are entitled to such dividends as our board of directors (the “Board of Directors”
or “Board”) may declare from time to time out of legally available funds, subject to the preferential rights of the holders
of any shares of our preferred stock that are outstanding or that we may issue in the future. Currently, we do not pay any dividends on
our common stock. Each holder of our common stock is entitled to one vote per share. In this prospectus, we provide a general description
of, among other things, the rights and restrictions that apply to holders of our common stock.
Preferred Stock
We currently have authorized
5,000,000 shares of preferred stock, par value $0.0001 per share. There are currently no shares of preferred stock outstanding. Any authorized
and undesignated shares of preferred stock may be issued from time to time in one or more additional series pursuant to a resolution or
resolutions providing for such issue duly adopted by our Board of Directors (authority to do so being hereby expressly vested in the Board
of Directors). The Board of Directors is further authorized, subject to limitations prescribed by law, to fix by resolution or resolutions
the designations, powers, preferences and rights, and the qualifications, limitations or restrictions thereof, of any wholly unissued
series of preferred stock, including without limitation authority to fix by resolution or resolutions the dividend rights, dividend rate,
conversion rights, voting rights, rights and terms of redemption (including sinking fund provisions), redemption price or prices, and
liquidation preferences of any such series, and the number of shares constituting any such series and the designation thereof, or any
of the foregoing.
The rights, preferences, privileges,
and restrictions granted to or imposed upon any series of preferred stock that we offer and sell under this prospectus and applicable
prospectus supplements will be set forth in a certificate of designation relating to the series. We will incorporate by reference into
the registration statement of which this prospectus is a part the form of any certificate of designation that describes the terms of the
series of preferred stock we are offering before the issuance of shares of that series of preferred stock. You should read any prospectus
supplement and any free writing prospectus that we may authorize to be provided to you related to the series of preferred stock being
offered, as well as the complete certificate of designation that contains the terms of the applicable series of preferred stock.
Debt Securities
We may offer general debt
obligations, which may be secured or unsecured, senior or subordinated, and convertible into shares of our common stock. In this prospectus,
we refer to the senior debt securities and the subordinated debt securities together as the “debt securities.” We may issue
debt securities under a note purchase agreement or under an indenture to be entered between us and a trustee and forms of the senior and
subordinated indentures are included as an exhibit to the registration statement of which this prospectus is a part. The indentures do
not limit the amount of securities that may be issued under it and provides that debt securities may be issued in one or more series.
The senior debt securities will have the same rank as all of our other indebtedness that is not subordinated. The subordinated debt securities
will be subordinated to our senior debt on terms set forth in the applicable prospectus supplement. In addition, the subordinated debt
securities will be effectively subordinated to creditors and preferred stockholders of our subsidiaries. Our Board of Directors will determine
the terms of each series of debt securities being offered. This prospectus contains only general terms and provisions of the debt securities.
The applicable prospectus supplement will describe the particular terms of the debt securities offered thereby. You should read any prospectus
supplement and any free writing prospectus that we may authorize to be provided to you related to the series of debt securities being
offered, as well as the complete note agreements and/or indentures that contain the terms of the debt securities. Forms of indentures
have been filed as exhibits to the registration statement of which this prospectus is a part, and supplemental indentures and forms of
debt securities containing the terms of debt securities being offered will be incorporated by reference into the registration statement
of which this prospectus is a part from reports we file with the SEC.
Warrants
We may offer warrants for
the purchase of shares of our common stock or preferred stock or of debt securities. We may issue the warrants by themselves or together
with common stock, preferred stock or debt securities, and the warrants may be attached to or separate from any offered securities. Any
warrants issued under this prospectus may be evidenced by warrant certificates. Warrants may be issued under a separate warrant agreement
to be entered into between us and the investors or a warrant agent. Our Board of Directors will determine the terms of the warrants.
This prospectus contains only general terms and provisions of the warrants. The applicable prospectus supplement will describe the particular
terms of the warrants being offered thereby. You should read any prospectus supplement and any free writing prospectus that we may authorize
to be provided to you related to the series of warrants being offered, as well as the complete warrant agreements that contain the terms
of the warrants. Specific warrant agreements will contain additional important terms and provisions and will be incorporated by reference
into the registration statement of which this prospectus is a part from reports we file with the SEC.
Rights
We may issue rights to our
stockholders to purchase shares of our common stock, preferred stock or the other securities described in this prospectus. We may offer
rights separately or together with one or more additional rights, debt securities, preferred stock, common stock or warrants, or any combination
of those securities in the form of units, as described in the applicable prospectus supplement. Each series of rights will be issued under
a separate rights agreement to be entered into between us and a bank or trust company, as rights agent. The rights agent will act solely
as our agent in connection with the certificates relating to the rights of the series of certificates and will not assume any obligation
or relationship of agency or trust for or with any holders of rights certificates or beneficial owners of rights. The following description
sets forth certain general terms and provisions of the rights to which any prospectus supplement may relate. The particular terms of the
rights to which any prospectus supplement may relate and the extent, if any, to which the general provisions may apply to the rights so
offered will be described in the applicable prospectus supplement. To the extent that any particular terms of the rights, rights agreement
or rights certificates described in a prospectus supplement differ from any of the terms described below, then the terms described below
will be deemed to have been superseded by that prospectus supplement. Specific rights agreements will contain additional important terms
and provisions and will be incorporated by reference into the registration statement of which this prospectus is a part from reports we
file with the SEC.
Units
We may offer units consisting
of our common stock or preferred stock, debt securities and/or warrants to purchase any of these securities in one or more series. We
may evidence each series of units by unit certificates that we will issue under a separate agreement. We may enter into unit agreements
with a unit agent. Each unit agent will be a bank or trust company that we select. We will indicate the name and address of the unit agent
in the applicable prospectus supplement relating to a particular series of units. This prospectus contains only a summary of certain general
features of the units. The applicable prospectus supplement will describe the particular features of the units being offered thereby.
You should read any prospectus supplement and any free writing prospectus that we may authorize to be provided to you related to the series
of units being offered, as well as the complete unit agreements that contain the terms of the units. Specific unit agreements will contain
additional important terms and provisions and will be incorporated by reference into the registration statement of which this prospectus
is a part from reports we file with the SEC.
Corporate Information
The Company was incorporated
in November 2017. On September 18, 2020, we consummated a reorganizational merger (the “Reorganization”), pursuant to an Agreement
and Plan of Merger (the “Merger Agreement”), dated July 14, 2020, whereby Amesite Inc. (“Amesite Parent”), our
former parent corporation, merged with and into us, with our Company resulting as the surviving entity. In connection with the same, we
filed a Certificate of Ownership and Merger with the Secretary of State of the State of Delaware, and changed our name from “Amesite
Operating Company” to “Amesite Inc.” The stockholders of Amesite Parent approved the Merger Agreement on August 4, 2020.
The directors and officers of Amesite Parent became our directors and officers.
Pursuant
to the Merger Agreement, on the Effective Date, each share of Amesite Parent’s common stock, $0.0001 par value per share, issued
and outstanding immediately before the Effective Date, was converted, on a one-for-one basis, into shares of our common stock. Additionally,
each option or warrant to acquire shares of Amesite Parent outstanding immediately before the Effective Date was converted into and became
an equivalent option to acquire shares of our common stock, upon the same terms and conditions.
Our
corporate headquarters are located at 607 Shelby Street, Suite 700 PMB 214, Detroit, Michigan 48226, and our telephone number is (734)
876-8130. We maintain a website at www.amesite.com. The contents of, or information accessible through, our website are not part of this
Annual Report on Form 10-K, and our website address is included in this document as an inactive textual reference only. We make our filings
with the SEC, including our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and all amendments
to those reports, available free of charge on our website as soon as reasonably practicable after we file such reports with, or furnish
such reports to, the SEC. The public may read and copy the materials we file with the SEC at the SEC’s Public Reference Room at
100 F Street, NE, Washington, D.C. 20549. The public may also obtain information on the operation of the Public Reference Room by calling
the SEC at 1-800-SEC-0330. Additionally, the SEC maintains an internet site that contains reports, proxy and information statements and
other information. The address of the SEC’s website is www.sec.gov. The information contained in the SEC’s website is not
intended to be a part of this filing.
RISK FACTORS
An investment in our securities
involves a high degree of risk. This prospectus contains, and the prospectus supplement applicable to each offering of our securities
will contain, a discussion of the risks applicable to an investment in our securities. Prior to making a decision about investing in our
securities, you should carefully consider the specific factors discussed under the heading “Risk Factors” in this prospectus
and the applicable prospectus supplement, together with all of the other information contained or incorporated by reference in the prospectus
supplement or appearing or incorporated by reference in this prospectus. You should also consider the risks, uncertainties and assumptions
discussed under Item 1A, “Risk Factors,” in our Annual Report on Form 10-K for the fiscal year ended June 30,
2021, filed with the SEC on September 10, 2021, and any updates described in our Quarterly Reports on Form 10-Q, all of which are
incorporated herein by reference, and may be amended, supplemented or superseded from time to time by other reports we file with the SEC
in the future and any prospectus supplement related to a particular offering. The risks and uncertainties we have described are not the
only ones we face. Additional risks and uncertainties not presently known to us or that we currently deem immaterial may also affect our
operations. The occurrence of any of these known or unknown risks might cause you to lose all or part of your investment in the offered
securities.
FORWARD-LOOKING STATEMENTS
This prospectus and any accompanying
prospectus supplement, including the documents that we incorporate by reference, contains forward-looking statements which are made pursuant
to the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section
21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). These statements may be identified by such forward-looking
terminology as “may,” “should,” “expects,” “intends,” “plans,” “anticipates,”
“believes,” “estimates,” “predicts,” “potential,” “continue” or the negative
of these terms or other comparable terminology. Our forward-looking statements are based on a series of expectations, assumptions, estimates
and projections about our company, are not guarantees of future results or performance and involve substantial risks and uncertainty.
We may not actually achieve the plans, intentions or expectations disclosed in these forward-looking statements. Actual results or events
could differ materially from the plans, intentions and expectations disclosed in these forward-looking statements. Our business and our
forward-looking statements involve substantial known and unknown risks and uncertainties, including the risks and uncertainties inherent
in our statements regarding:
| ● | our
artificial intelligence (AI)-driven learning platform’s ability to enable businesses, universities, and non-profit organizations
to offer timely, improved popular courses and certification programs, without becoming software tech companies; |
| ● | our
planned online machine learning platform’s ability to result in opportunistic incremental revenue for colleges and universities,
and improved ability to garner state funds due to increased retention and graduation rates through use of machine learning and natural
language processing; |
| ● | our
ability to obtain additional funds for our operations; |
| ● | our
ability to obtain and maintain intellectual property protection for our technologies and our ability to operate our business without
infringing the intellectual property rights of others; |
| ● | our
reliance on third parties to conduct our business and studies; |
| ● | our
reliance on third party designers, suppliers, and partners to provide and maintain our learning platform; |
| ● | our
ability to attract and retain qualified key management and technical personnel; |
| ● | our
expectations regarding the time during which we will be an emerging growth company under the Jumpstart Our Business Startups Act, or
JOBS Act; |
| ● | our
financial performance; |
| ● | the
impact of government regulation and developments relating to our competitors or our industry; and |
| ● | other
risks and uncertainties, including those listed under the caption “Risk Factors.” |
All of our forward-looking
statements are as of the date of this prospectus only. In each case, actual results may differ materially from such forward-looking information.
We can give no assurance that such expectations or forward-looking statements will prove to be correct. An occurrence of, or any material
adverse change in, one or more of the risk factors or risks and uncertainties referred to in this prospectus or included in our other
public disclosures or our other periodic reports or other documents or filings filed with or furnished to the U.S. Securities and Exchange
Commission (the “SEC”) could materially and adversely affect our business, prospects, financial condition, and results of
operations. Except as required by law, we do not undertake or plan to update or revise any such forward-looking statements to reflect
actual results, changes in plans, assumptions, estimates or projections or other circumstances affecting such forward-looking statements
occurring after the date of this prospectus, even if such results, changes, or circumstances make it clear that any forward-looking information
will not be realized. Any public statements or disclosures by us following this prospectus that modify or impact any of the forward-looking
statements contained in this prospectus will be deemed to modify or supersede such statements in this prospectus.
This prospectus may include
market data and certain industry data and forecasts, which we may obtain from internal company surveys, market research, consultant surveys,
publicly available information, reports of governmental agencies and industry publications, articles, and surveys. Industry surveys, publications,
consultant surveys, and forecasts generally state that the information contained therein has been obtained from sources believed to be
reliable, but the accuracy and completeness of such information is not guaranteed. While we believe that such studies and publications
are reliable, we have not independently verified market and industry data from third-party sources.
USE OF PROCEEDS
Except as described in any
prospectus supplement and any free writing prospectus in connection with a specific offering, we currently intend to use the net proceeds
from the sale of the securities offered under this prospectus for general corporate purposes, capital expenditures, working capital and
general and administrative expenses. We may also use the net proceeds to repay any debts and/or invest in or acquire additional businesses,
products, or technologies on an opportunistic basis, although we have no current commitments with respect to any such investments or acquisitions
as of the date of this prospectus. We have not determined the amount of net proceeds to be used specifically for the foregoing purposes.
As a result, our management will have broad discretion in the allocation of the net proceeds and investors will be relying on the judgment
of our management regarding the application of the proceeds of any sale of the securities. Pending use of the net proceeds, we intend
to invest the proceeds in short-term, investment-grade, interest-bearing instruments.
Each time we offer securities under this prospectus, we will describe
the intended use of the net proceeds from that offering in the applicable prospectus supplement. The actual amount of net proceeds we
spend on a particular use will depend on many factors, including, our future capital expenditures, the amount of cash required by our
operations, and our future revenue growth, if any. Therefore, we will retain broad discretion in the use of the net proceeds.
DESCRIPTION OF CAPITAL STOCK
General
The following description
of our capital stock, together with any additional information we include in any applicable prospectus supplement or any related free
writing prospectus, summarizes the material terms and provisions of our common stock and the preferred stock that we may offer under this
prospectus. While the terms we have summarized below will apply generally to any future common stock or preferred stock that we may offer,
we will describe the particular terms of any class or series of these securities in more detail in the applicable prospectus supplement.
For the complete terms of our common stock and preferred stock, please refer to our Certificate of Incorporation and Bylaws that are incorporated
by reference into the registration statement of which this prospectus is a part or may be incorporated by reference in this prospectus
or any applicable prospectus supplement. The terms of these securities may also be affected by Delaware General Corporation Law (the “DGCL”).
The summary below and that contained in any applicable prospectus supplement or any related free writing prospectus are qualified in their
entirety by reference to our Certificate of Incorporation and our Bylaws.
The Company is authorized
to issue 105,000,000 shares of capital stock, par value $0.0001 per share, of which 100,000,000 are shares of common stock and 5,000,000
are shares of “blank check” preferred stock.
As of the date of this prospectus,
there were [ ] shares of our common stock issued and outstanding and no shares of preferred stock issued and outstanding
Common Stock
Voting
The holders of our common
stock are entitled to one vote for each share held on all matters to be voted on by the Company’s stockholders. There shall be no
cumulative voting.
Dividends
The holders of shares of our
common stock are entitled to dividends when and as declared by the Board from funds legally available therefor if, as and when determined
by the Board of Directors of the Company in their sole discretion, subject to provisions of law, and any provision of the Company’s
Certificate of Incorporation, as amended from time to time. There are no preemptive, conversion or redemption privileges, nor sinking
fund provisions with respect to the common stock.
Liquidation
In the event of any voluntary
or involuntary liquidation, dissolution or winding up of our affairs, the holders of our common stock will be entitled to share ratably
in the net assets legally available for distribution to stockholders after the payment of or provision for all of our debts and other
liabilities.
Fully Paid and Non-assessable
All outstanding shares of
common stock are duly authorized, validly issued, fully paid and non-assessable.
Preferred Stock
We are authorized to issue
up to 5,000,000 shares of preferred stock. This preferred stock may be issued in one or more series, the terms of which may be determined
at the time of issuance by our board of directors without further action by stockholders. The terms of any series of preferred stock may
include voting rights (including the right to vote as a series on particular matters), preferences as to dividend, liquidation, conversion
and redemption rights and sinking fund provisions. No preferred stock is currently outstanding. The issuance of any preferred stock could
materially adversely affect the rights of the holders of our common stock, and therefore, reduce the value of our common stock and the
Notes. In particular, specific rights granted to future holders of preferred stock could be used to restrict our ability to merge with,
or sell our assets to, a third party and thereby preserve control by the present management.
Exclusive Forum
Our Certificate of Incorporation
provides that unless the Company consents in writing to the selection of an alternative forum, the State of Delaware is the sole
and exclusive forum for: (i) any derivative action or proceeding brought on behalf of the Company, (ii) any action asserting a claim of
breach of a fiduciary duty owed by any director, officer or other employee of the Company to the Company or the Company’s stockholders,
(iii) any action asserting a claim against the Company, its directors, officers or employees arising pursuant to any provision of the
DGCL or our Certificate of Incorporation or the Bylaws, or (iv) any action asserting a claim against the Company, its directors, officers,
employees or agents governed by the internal affairs doctrine, except for, as to each of (i) through (iv) above, any claim as to which
the Court of Chancery determines that there is an indispensable party not subject to the jurisdiction of the Court of Chancery (and the
indispensable party does not consent to the personal jurisdiction of the Court of Chancery within ten days following such determination),
which is vested in the exclusive jurisdiction of a court or forum other than the Court of Chancery, or for which the Court of Chancery
does not have subject matter jurisdiction.
Additionally, our Certificate
of Incorporation provide that unless the Company consents in writing to the selection of an alternative forum, the federal district courts
of the United States of America will be the exclusive forum for the resolution of any complaint asserting a cause of action arising under
the Securities Act. Any person or entity purchasing or otherwise acquiring any interest in shares of capital stock of the Corporation
are deemed to have notice of and consented to this provision. The Supreme Court of Delaware has held that this type of exclusive federal
forum provision is enforceable. There may be uncertainty, however, as to whether courts of other jurisdictions would enforce such a provision,
if applicable.
Transfer Agent
The transfer agent and registrar
for our common stock is Continental Stock Transfer & Trust Company.
Changes in Authorized Number
The Board of Directors is
expressly authorized to increase or decrease the number of shares of any series subsequent to the issuance of shares of that series, but
not below the number of shares of such series then outstanding. The number of authorized shares of Preferred Stock may be increased or
decreased (but not below the number of shares thereof then outstanding) by the affirmative vote of the holders of a majority of the voting
power of the stock of the Company entitled to vote thereon, without a separate vote of the holders of the Preferred Stock, or of any series
thereof, unless a vote of any such holders is required pursuant to the terms of any Certificate of Designation filed with respect to any
series of Preferred Stock.
Delaware Anti-Takeover Statute
We may become subject to Section
203 of the Delaware General Corporation Law, which prohibits persons deemed to be “interested stockholders” from engaging
in a “business combination” with a publicly held Delaware corporation for three years following the date these persons become
interested stockholders unless the business combination is, or the transaction in which the person became an interested stockholder was,
approved in a prescribed manner or another prescribed exception applies. Generally, an “interested stockholder” is a person
who, together with affiliates and associates, owns, or within three years prior to the determination of interested stockholder status
did own, 15% or more of a corporation’s voting stock. Generally, a “business combination” includes a merger, asset or
stock sale, or other transaction resulting in a financial benefit to the interested stockholder. The existence of this provision may have
an anti-takeover effect with respect to transactions not approved in advance by the Board of Directors. A Delaware corporation may “opt
out” of these provisions with an express provision in its original certificate of incorporation or an express provision in its certificate
of incorporation or bylaws resulting from a stockholders’ amendment approved by at least a majority of the outstanding voting shares.
We have not opted out of these provisions. As a result, mergers or other takeover or change in control attempts of us may be discouraged
or prevented.
The Bylaws establish an advance
notice procedure for stockholder proposals to be brought before an annual meeting of our stockholders, including proposed nominations
of persons for election to our board of directors. At an annual meeting, stockholders may only consider proposals or nominations specified
in the notice of meeting or brought before the meeting by or at the direction of our board of directors. Stockholders may also consider
a proposal or nomination by a person who was a stockholder at the time of giving notice and at the time of the meeting, who is entitled
to vote at the meeting and who has complied with the notice requirements of the Bylaws in all respects. The Bylaws do not give our board
of directors the power to approve or disapprove stockholder nominations of candidates or proposals regarding other business to be conducted
at a special or annual meeting of our stockholders. However, the Bylaws may have the effect of precluding the conduct of certain business
at a meeting if the proper procedures are not followed. These provisions may also discourage or deter a potential acquirer from conducting
a solicitation of proxies to elect the acquirer’s own slate of directors or otherwise attempting to obtain control of our company.
The Bylaws provide that a
special meeting of our stockholders may be called only by our Secretary at the direction of the Board or by resolution adopted by a majority
of our board of directors. Because our stockholders do not have the right to call a special meeting, a stockholder could not force stockholder
consideration of a proposal over the opposition of our board of directors by calling a special meeting of stockholders prior to such time
as a majority of our board of directors or the Secretary believe the matter should be considered or until the next annual meeting provided that
the requestor met the notice requirements. The restriction on the ability of stockholders to call a special meeting means that a proposal
to replace our board of directors also could be delayed until the next annual meeting.
DESCRIPTION OF DEBT SECURITIES
The following description,
together with the additional information we include in any applicable prospectus supplements or free writing prospectuses, summarizes
the material terms and provisions of the debt securities that we may offer under this prospectus. We may issue debt securities, in one
or more series, as either senior or subordinated debt or as senior or subordinated convertible debt. While the terms we have summarized
below will apply generally to any future debt securities we may offer under this prospectus, we will describe the particular terms of
any debt securities that we may offer in more detail in the applicable prospectus supplement or free writing prospectus. The terms of
any debt securities we offer under a prospectus supplement may differ from the terms we describe below. However, no prospectus supplement
shall fundamentally change the terms that are set forth in this prospectus or offer a security that is not registered and described in
this prospectus at the time of its effectiveness. As of the date of this prospectus, we have no outstanding registered debt securities.
Unless the context requires otherwise, whenever we refer to the “indentures,” we also are referring to any supplemental indentures
that specify the terms of a particular series of debt securities.
We will issue any senior debt
securities under the senior indenture that we will enter into with the trustee named in the senior indenture. We will issue any subordinated
debt securities under the subordinated indenture and any supplemental indentures that we will enter into with the trustee named in the
subordinated indenture. We have filed forms of these documents as exhibits to the registration statement, of which this prospectus is
a part, and supplemental indentures and forms of debt securities containing the terms of the debt securities being offered will be filed
as exhibits to the registration statement of which this prospectus is a part or will be incorporated by reference from reports that we
file with the SEC.
The indentures will be qualified
under the Trust Indenture Act of 1939, as amended (the “Trust Indenture Act”). We use the term “trustee” to refer
to either the trustee under the senior indenture or the trustee under the subordinated indenture, as applicable.
The following summaries of
material provisions of the senior debt securities, the subordinated debt securities and the indentures are subject to, and qualified in
their entirety by reference to, all of the provisions of the indenture and any supplemental indentures applicable to a particular series
of debt securities. We urge you to read the applicable prospectus supplements and any related free writing prospectuses related to the
debt securities that we may offer under this prospectus, as well as the complete indentures that contains the terms of the debt securities.
Except as we may otherwise indicate, the terms of the senior indenture and the subordinated indenture are identical.
General
The terms of each series of
debt securities will be established by or pursuant to a resolution of our Board of Directors and set forth or determined in the manner
provided in an officers’ certificate or by a supplemental indenture. Debt securities may be issued in separate series without limitation
as to aggregate principal amount. We may specify a maximum aggregate principal amount for the debt securities of any series. We will describe
in the applicable prospectus supplement the terms of the series of debt securities being offered, including:
|
● |
the principal amount being offered, and if a series, the total amount authorized and the total amount outstanding; |
|
● |
any limit on the amount that may be issued; |
|
● |
whether or not we will issue the series of debt securities in global form, and, if so, the terms and who the depositary will be; |
|
● |
whether and under what circumstances, if any, we will pay additional amounts on any debt securities held by a person who is not a United States person for tax purposes, and whether we can redeem the debt securities if we have to pay such additional amounts; |
|
● |
the annual interest rate, which may be fixed or variable, or the method for determining the rate and the date interest will begin to accrue, the dates interest will be payable and the regular record dates for interest payment dates or the method for determining such dates; |
|
● |
whether or not the debt securities will be secured or unsecured, and the terms of any secured debt; |
|
● |
the terms of the subordination of any series of subordinated debt; |
|
● |
the place where payments will be made; |
|
● |
restrictions on transfer, sale or other assignment, if any; |
|
● |
our right, if any, to defer payment of interest and the maximum length of any such deferral period; |
|
● |
the date, if any, after which, and the price at which, we may, at our option, redeem the series of debt securities pursuant to any optional or provisional redemption provisions and the terms of those redemption provisions; |
|
● |
provisions for a sinking fund purchase or other analogous fund, if any, including the date, if any, on which, and the price at which we are obligated, pursuant thereto or otherwise, to redeem, or at the holder’s option, to purchase, the series of debt securities and the currency or currency unit in which the debt securities are payable; |
|
● |
whether the indenture will restrict our ability or the ability of our subsidiaries, if any, to: |
|
○ |
incur additional indebtedness; |
|
○ |
issue additional securities; |
|
○ |
pay dividends or make distributions in respect of our capital stock or the capital stock of our subsidiaries; |
|
○ |
redeem capital stock; |
|
○ |
place restrictions on our subsidiaries’ ability to pay dividends, make distributions or transfer assets; |
|
○ |
make investments or other restricted payments; |
|
○ |
sell or otherwise dispose of assets; |
|
○ |
enter into sale-leaseback transactions; |
|
○ |
engage in transactions with stockholders or affiliates; |
|
○ |
issue or sell stock of our subsidiaries; or |
|
○ |
effect a consolidation or merger; |
|
● |
whether the indenture will require us to maintain any interest coverage, fixed charge, cash flow-based, asset-based or other financial ratios; |
|
● |
a discussion of certain material or special United States federal income tax considerations applicable to the debt securities; |
|
● |
information describing any book-entry features; |
|
● |
the applicability of the provisions in the indenture on discharge; |
|
● |
whether the debt securities are to be offered at a price such that they will be deemed to be offered at an “original issue discount” as defined in paragraph (a) of Section 1273 of the Internal Revenue Code of 1986, as amended; |
|
● |
the denominations in which we will issue the series of debt securities, if other than denominations of $1,000 and any integral multiple thereof; |
|
● |
the currency of payment of debt securities if other than U.S. dollars and the manner of determining the equivalent amount in U.S. dollars; and |
|
● |
any other specific terms, preferences, rights or limitations of, or restrictions on, the debt securities, including any additional events of default or covenants provided with respect to the debt securities, and any terms that may be required by us or advisable under applicable laws or regulations. |
Conversion or Exchange Rights
We will set forth in the applicable
prospectus supplement the terms under which a series of debt securities may be convertible into or exchangeable for our common stock,
our preferred stock or other securities (including securities of a third party). We will include provisions as to whether conversion or
exchange is mandatory, at the option of the holder or at our option. We may include provisions pursuant to which the number of shares
of our common stock, our preferred stock or other securities (including securities of a third party) that the holders of the series of
debt securities receive would be subject to adjustment.
Consolidation, Merger or Sale
Unless we provide otherwise
in the prospectus supplement applicable to a particular series of debt securities, the indentures will not contain any covenant that restricts
our ability to merge or consolidate, or sell, convey, transfer or otherwise dispose of all or substantially all of our assets. However,
any successor to or acquirer of such assets must assume all of our obligations under the indentures or the debt securities, as appropriate.
If the debt securities are convertible into or exchangeable for our other securities or securities of other entities, the person with
whom we consolidate or merge or to whom we sell all of our property must make provisions for the conversion of the debt securities
into securities that the holders of the debt securities would have received if they had converted the debt securities before the consolidation,
merger or sale.
Events of Default under the Indenture
Unless we provide otherwise
in the prospectus supplement applicable to a particular series of debt securities, the following are events of default under the indentures
with respect to any series of debt securities that we may issue:
|
● |
if we fail to pay interest when due and payable and our failure continues for 90 days and the time for payment has not been extended; |
|
● |
if we fail to pay the principal, premium or sinking fund payment, if any, when due and payable at maturity, upon redemption or repurchase or otherwise, and the time for payment has not been extended; |
|
● |
if we fail to observe or perform any other covenant contained in the debt securities or the indentures, other than a covenant specifically relating to another series of debt securities, and our failure continues for 90 days after we receive notice from the trustee or we and the trustee receive notice from the holders of at least 25% in aggregate principal amount of the outstanding debt securities of the applicable series; and |
|
● |
if specified events of bankruptcy, insolvency or reorganization occur. |
We will describe in each applicable
prospectus supplement any additional events of default relating to the relevant series of debt securities.
If an event of default with
respect to debt securities of any series occurs and is continuing, other than an event of default specified in the last bullet point above,
the trustee or the holders of at least 25% in aggregate principal amount of the outstanding debt securities of that series, by notice
to us in writing, and to the trustee if notice is given by such holders, may declare the unpaid principal, premium, if any, and accrued
interest, if any, due and payable immediately. If an event of default arises due to the occurrence of certain specified bankruptcy, insolvency
or reorganization events, the unpaid principal, premium, if any, and accrued interest, if any, of each issue of debt securities then outstanding
shall be due and payable without any notice or other action on the part of the trustee or any holder.
The holders of a majority
in principal amount of the outstanding debt securities of an affected series may waive any default or event of default with respect to
the series and its consequences, except defaults or events of default regarding payment of principal, premium, if any, or interest, unless
we have cured the default or event of default in accordance with the indenture. Any waiver shall cure the default or event of default.
Subject to the terms of the
indentures, if an event of default under an indenture shall occur and be continuing, the trustee will be under no obligation to exercise
any of its rights or powers under such indenture at the request or direction of any of the holders of the applicable series of debt securities,
unless such holders have offered the trustee reasonable indemnity or security satisfactory to it against any loss, liability or expense.
The holders of a majority in principal amount of the outstanding debt securities of any series will have the right to direct the time,
method and place of conducting any proceeding for any remedy available to the trustee, or exercising any trust or power conferred on the
trustee, with respect to the debt securities of that series, provided that:
|
● |
the direction so given by the holder is not in conflict with any law or the applicable indenture; and |
|
● |
subject to its duties under the Trust Indenture Act, the trustee need not take any action that might involve it in personal liability or might be unduly prejudicial to the holders not involved in the proceeding. |
The indentures will provide
that if an event of default has occurred and is continuing, the trustee will be required in the exercise of its powers to use the degree
of care that a prudent person would use in the conduct of its own affairs. The trustee, however, may refuse to follow any direction that
conflicts with law or the indenture, or that the trustee determines is unduly prejudicial to the rights of any other holder of the relevant
series of debt securities, or that would involve the trustee in personal liability. Prior to taking any action under the indentures, the
trustee will be entitled to indemnification against all costs, expenses and liabilities that would be incurred by taking or not taking
such action.
A holder of the debt securities
of any series will have the right to institute a proceeding under the indentures or to appoint a receiver or trustee, or to seek other
remedies only if:
|
● |
the holder has given written notice to the trustee of a continuing event of default with respect to that series; |
|
● |
the holders of at least 25% in aggregate principal amount of the outstanding debt securities of that series have made a written request and such holders have offered reasonable indemnity to the trustee or security satisfactory to it against any loss, liability or expense or to be incurred in compliance with instituting the proceeding as trustee; and |
|
● |
the trustee does not institute the proceeding, and does not receive from the holders of a majority in aggregate principal amount of the outstanding debt securities of that series other conflicting directions within 90 days after the notice, request and offer. |
These limitations do not apply
to a suit instituted by a holder of debt securities if we default in the payment of the principal, premium, if any, or interest on, the
debt securities, or other defaults that may be specified in the applicable prospectus supplement.
We will periodically file
statements with the trustee regarding our compliance with specified covenants in the indentures.
The indentures will provide
that if a default occurs and is continuing and is actually known to a responsible officer of the trustee, the trustee must mail to each
holder notice of the default within the earlier of 90 days after it occurs and 30 days after it is known by a responsible officer of the
trustee or written notice of it is received by the trustee, unless such default has been cured or waived. Except in the case of a default
in the payment of principal or premium of, or interest on, any debt security or certain other defaults specified in an indenture, the
trustee shall be protected in withholding such notice if and so long as the Board of Directors, the executive committee or a trust committee
of directors, or responsible officers of the trustee, in good faith determine that withholding notice is in the best interests of holders
of the relevant series of debt securities.
Modification of Indenture; Waiver
Subject to the terms of the
indenture for any series of debt securities that we may issue, we and the trustee may change an indenture without the consent of any holders
with respect to the following specific matters:
|
● |
to fix any ambiguity, defect or inconsistency in the indenture; |
|
● |
to comply with the provisions described above under “Description of Debt Securities — Consolidation, Merger or Sale;” |
|
● |
to comply with any requirements of the SEC in connection with the qualification of any indenture under the Trust Indenture Act; |
|
● |
to add to, delete from or revise the conditions, limitations and restrictions on the authorized amount, terms or purposes of issue, authentication and delivery of debt securities, as set forth in the indenture; |
|
● |
to provide for the issuance of, and establish the form and terms and conditions of, the debt securities of any series as provided under “Description of Debt Securities — General,” to establish the form of any certifications required to be furnished pursuant to the terms of the indenture or any series of debt securities, or to add to the rights of the holders of any series of debt securities; |
|
● |
to evidence and provide for the acceptance of appointment hereunder by a successor trustee; |
|
● |
to provide for uncertificated debt securities and to make all appropriate changes for such purpose; |
|
● |
to add such new covenants, restrictions, conditions or provisions for the benefit of the holders, to make the occurrence, or the occurrence and the continuance, of a default in any such additional covenants, restrictions, conditions or provisions an event of default or to surrender any right or power conferred to us in the indenture; or |
|
● |
to change anything that does not adversely affect the interests of any holder of debt securities of any series in any material respect. |
In addition, under the indentures,
the rights of holders of a series of debt securities may be changed by us and the trustee with the written consent of the holders of at
least a majority in aggregate principal amount of the outstanding debt securities of each series that is affected. However, subject to
the terms of the indenture for any series of debt securities that we may issue or otherwise provided in the prospectus supplement applicable
to a particular series of debt securities, we and the trustee may only make the following changes with the consent of each holder of any
outstanding debt securities affected:
|
● |
extending the stated maturity of the series of debt securities; |
|
● |
reducing the principal amount, reducing the rate of or extending the time of payment of interest, or reducing any premium payable upon the redemption or repurchase of any debt securities; or |
|
● |
reducing the percentage of debt securities, the holders of which are required to consent to any amendment, supplement, modification or waiver. |
Discharge
Each indenture provides that,
subject to the terms of the indenture and any limitation otherwise provided in the prospectus supplement applicable to a particular series
of debt securities, we may elect to be discharged from our obligations with respect to one or more series of debt securities, except for
specified obligations, including obligations to:
|
● |
register the transfer or exchange of debt securities of the series; |
|
● |
replace stolen, lost or mutilated debt securities of the series; |
|
● |
maintain paying agencies; |
|
● |
hold monies for payment in trust; |
|
● |
recover excess money held by the trustee; |
|
● |
compensate and indemnify the trustee; and |
|
● |
appoint any successor trustee. |
In order to exercise our rights
to be discharged, we will deposit with the trustee money or government obligations sufficient to pay all the principal of, and any premium
and interest on, the debt securities of the series on the dates payments are due.
Form, Exchange and Transfer
We will issue the debt securities
of each series only in fully registered form without coupons and, unless we otherwise specify in the applicable prospectus supplement,
in denominations of $1,000 and any integral multiple thereof. The indentures will provide that we may issue debt securities of a series
in temporary or permanent global form and as book-entry securities that will be deposited with, or on behalf of, The Depository Trust
Company or another depositary named by us and identified in a prospectus supplement with respect to that series. See “Legal Ownership
of Securities” below for a further description of the terms relating to any book-entry securities.
At the option of the holder,
subject to the terms of the indentures and the limitations applicable to global securities described in the applicable prospectus supplement,
the holder of the debt securities of any series can exchange the debt securities for other debt securities of the same series, in any
authorized denomination and of like tenor and aggregate principal amount.
Subject to the terms of the
indentures and the limitations applicable to global securities set forth in the applicable prospectus supplement, holders of the debt
securities may present the debt securities for exchange or for registration of transfer, duly endorsed or with the form of transfer endorsed
thereon duly executed if so required by us or the security registrar, at the office of the security registrar or at the office of any
transfer agent designated by us for this purpose. Unless otherwise provided in the debt securities that the holder presents for transfer
or exchange, we will make no service charge for any registration of transfer or exchange, but we may require payment of any taxes or other
governmental charges.
We will name in the applicable
prospectus supplement the security registrar, and any transfer agent in addition to the security registrar, that we initially designate
for any debt securities. We may at any time designate additional transfer agents or rescind the designation of any transfer agent or approve
a change in the office through which any transfer agent acts, except that we will be required to maintain a transfer agent in each place
of payment for the debt securities of each series.
If we elect to redeem the
debt securities of any series, we will not be required to:
|
● |
issue, register the transfer of, or exchange any debt securities of that series during a period beginning at the opening of business 15 days before the day of mailing of a notice of redemption of any debt securities that may be selected for redemption and ending at the close of business on the day of the mailing; or |
|
● |
register the transfer of or exchange any debt securities so selected for redemption, in whole or in part, except the unredeemed portion of any debt securities we are redeeming in part. |
Information Concerning the Trustee
The trustee, other than during
the occurrence and continuance of an event of default under an indenture, undertakes to perform only those duties as are specifically
set forth in the applicable indenture and is under no obligation to exercise any of the powers given it by the indentures at the request
of any holder of debt securities unless it is offered reasonable security and indemnity against the costs, expenses and liabilities that
it might incur. However, upon an event of default under an indenture, the trustee must use the same degree of care as a prudent person
would exercise or use in the conduct of his or her own affairs.
Payment and Paying Agents
Unless we otherwise indicate
in the applicable prospectus supplement, we will make payment of the interest on any debt securities on any interest payment date to the
person in whose name the debt securities, or one or more predecessor securities, are registered at the close of business on the regular
record date for the interest payment.
We will pay principal of and
any premium and interest on the debt securities of a particular series at the office of the paying agents designated by us, except that
unless we otherwise indicate in the applicable prospectus supplement, we will make interest payments by check that we will mail to the
holder or by wire transfer to certain holders. Unless we otherwise indicate in the applicable prospectus supplement, we will designate
the corporate trust office of the trustee as our sole paying agent for payments with respect to debt securities of each series. We will
name in the applicable prospectus supplement any other paying agents that we initially designate for the debt securities of a particular
series. We will maintain a paying agent in each place of payment for the debt securities of a particular series.
All money we pay to a paying
agent or the trustee for the payment of the principal of or any premium or interest on any debt securities that remains unclaimed at the
end of two years after such principal, premium or interest has become due and payable will be repaid to us, and the holder of the debt
security thereafter may look only to us for payment thereof.
Governing Law
The indentures and the debt
securities will be governed by and construed in accordance with the laws of the State of New York, except to the extent that the Trust
Indenture Act is applicable.
Ranking Debt Securities
The subordinated debt securities
will be unsecured and will be subordinate and junior in priority of payment to certain other indebtedness to the extent described in a
prospectus supplement. The subordinated indenture does not limit the amount of subordinated debt securities that we may issue. It also
does not limit us from issuing any other secured or unsecured debt.
The senior debt securities
will be unsecured and will rank equally in right of payment to all our other senior unsecured debt. The senior indenture does not limit
the amount of senior debt securities that we may issue. It also does not limit us from issuing any other secured or unsecured debt.
DESCRIPTION OF WARRANTS
The following description,
together with the additional information we may include in any applicable prospectus supplements and free writing prospectuses, summarizes
the material terms and provisions of the warrants that we may offer under this prospectus, which may consist of warrants to purchase common
stock, preferred stock or debt securities and may be issued in one or more series. Warrants may be offered independently or together with
common stock, preferred stock or debt securities offered by any prospectus supplement, and may be attached to or separate from those securities.
While the terms we have summarized below will apply generally to any warrants that we may offer under this prospectus, we will describe
the particular terms of any series of warrants that we may offer in more detail in the applicable prospectus supplement and any applicable
free writing prospectus. The terms of any warrants offered under a prospectus supplement may differ from the terms described below. However,
no prospectus supplement will fundamentally change the terms that are set forth in this prospectus or offer a security that is not registered
and described in this prospectus at the time of its effectiveness.
We may issue the warrants
under a warrant agreement that we will enter into with a warrant agent to be selected by us. If selected, the warrant agent will act solely
as an agent of ours in connection with the warrants and will not act as an agent for the holders or beneficial owners of the warrants.
If applicable, we will file as exhibits to the registration statement of which this prospectus is a part, or will incorporate by reference
from a Current Report on Form 8-K that we file with the SEC, the form of warrant agreement, including a form of warrant certificate,
that describes the terms of the particular series of warrants we are offering before the issuance of the related series of warrants. The
following summaries of material provisions of the warrants and the warrant agreements are subject to, and qualified in their entirety
by reference to, all the provisions of the warrant agreement and warrant certificate applicable to a particular series of warrants. We
urge you to read the applicable prospectus supplement and any applicable free writing prospectus related to the particular series of warrants
that we sell under this prospectus, as well as the complete warrant agreements and warrant certificates that contain the terms of the
warrants.
General
We will describe in the applicable
prospectus supplement the terms relating to a series of warrants, including:
|
● |
the offering price and aggregate number of warrants offered; |
|
● |
the currency for which the warrants may be purchased; |
|
● |
if applicable, the designation and terms of the securities with which the warrants are issued and the number of warrants issued with each such security or each principal amount of such security; |
|
● |
if applicable, the date on and after which the warrants and the related securities will be separately transferable; |
|
● |
in the case of warrants to purchase debt securities, the principal amount of debt securities purchasable upon exercise of one warrant and the price at, and currency in which, this principal amount of debt securities may be purchased upon such exercise; |
|
● |
in the case of warrants to purchase common stock or preferred stock, the number of shares of common stock or preferred stock, as the case may be, purchasable upon the exercise of one warrant and the price at which these shares may be purchased upon such exercise; |
|
● |
the effect of any merger, consolidation, sale or other disposition of our business on the warrant agreements and the warrants; |
|
● |
the terms of any rights to redeem or call the warrants; |
|
● |
any provisions for changes to or adjustments in the exercise price or number of securities issuable upon exercise of the warrants; |
|
● |
the dates on which the right to exercise the warrants will commence and expire; |
|
● |
the manner in which the warrant agreements and warrants may be modified; |
|
● |
United States federal income tax consequences of holding or exercising the warrants; |
|
● |
the terms of the securities issuable upon exercise of the warrants; and |
|
● |
any other specific terms, preferences, rights or limitations of or restrictions on the warrants. |
|
● |
before exercising their warrants, holders of warrants will not have any of the rights of holders of the securities purchasable upon such exercise, including: |
|
● |
in the case of warrants to purchase debt securities, the right to receive payments of principal of, or premium, if any, or interest on, the debt securities purchasable upon exercise or to enforce covenants in the applicable indenture; or |
|
● |
in the case of warrants to purchase common stock or preferred stock, the right to receive dividends, if any, or, payments upon our liquidation, dissolution or winding up or to exercise voting rights, if any. |
Exercise of Warrants
Each warrant will entitle
the holder to purchase the securities that we specify in the applicable prospectus supplement at the exercise price that we describe in
the applicable prospectus supplement. Unless we otherwise specify in the applicable prospectus supplement, holders of the warrants may
exercise the warrants at any time up to the specified time on the expiration date that we set forth in the applicable prospectus supplement.
After the close of business on the expiration date, unexercised warrants will become void.
Holders of the warrants may
exercise the warrants by delivering the warrant certificate representing the warrants to be exercised together with specified information,
and paying the required amount to the warrant agent in immediately available funds, as provided in the applicable prospectus supplement.
We will set forth on the reverse side of the warrant certificate and in the applicable prospectus supplement the information that the
holder of the warrant will be required to deliver to us or the warrant agent as applicable.
Upon receipt of the required
payment and the warrant certificate properly completed and duly executed at the corporate trust office of the warrant agent or any other
office indicated in the applicable prospectus supplement, we will issue and deliver the securities purchasable upon such exercise. If
fewer than all of the warrants represented by the warrant certificate are exercised, then we will issue a new warrant certificate for
the remaining amount of warrants. If we so indicate in the applicable prospectus supplement, holders of the warrants may surrender securities
as all or part of the exercise price for warrants.
Enforceability of Rights by Holders of Warrants
If selected, each warrant
agent will act solely as our agent under the applicable warrant agreement and will not assume any obligation or relationship of agency
or trust with any holder of any warrant. A single bank or trust company may act as warrant agent for more than one issue of warrants.
A warrant agent will have no duty or responsibility in case of any default by us under the applicable warrant agreement or warrant, including
any duty or responsibility to initiate any proceedings at law or otherwise, or to make any demand upon us. Any holder of a warrant may,
without the consent of the related warrant agent or the holder of any other warrant, enforce by appropriate legal action its right to
exercise, and receive the securities purchasable upon exercise of, its warrants.
DESCRIPTION OF RIGHTS
General
We may issue rights to our
stockholders to purchase shares of our common stock, preferred stock or the other securities described in this prospectus. We may offer
rights separately or together with one or more additional rights, debt securities, preferred stock, common stock or warrants, or any combination
of those securities in the form of units, as described in the applicable prospectus supplement. Each series of rights will be issued under
a separate rights agreement to be entered into between us and a bank or trust company, as rights agent. The rights agent will act solely
as our agent in connection with the certificates relating to the rights of the series of certificates and will not assume any obligation
or relationship of agency or trust for or with any holders of rights certificates or beneficial owners of rights. The following description
sets forth certain general terms and provisions of the rights to which any prospectus supplement may relate. The particular terms of the
rights to which any prospectus supplement may relate and the extent, if any, to which the general provisions may apply to the rights so
offered will be described in the applicable prospectus supplement. To the extent that any particular terms of the rights, rights agreement
or rights certificates described in a prospectus supplement differ from any of the terms described below, then the terms described below
will be deemed to have been superseded by that prospectus supplement. We encourage you to read the applicable rights agreement and rights
certificate for additional information before you decide whether to purchase any of our rights. We will provide in a prospectus supplement
the following terms of the rights being issued:
|
● |
the date of determining the stockholders entitled to the rights distribution; |
|
● |
the aggregate number of shares of common stock, preferred stock or other securities purchasable upon exercise of the rights; |
|
● |
the aggregate number of rights issued; |
|
● |
whether the rights are transferrable and the date, if any, on and after which the rights may be separately transferred; |
|
● |
the date on which the right to exercise the rights will commence, and the date on which the right to exercise the rights will expire; |
|
● |
the method by which holders of rights will be entitled to exercise; |
|
● |
the conditions to the completion of the offering, if any; |
|
● |
the withdrawal, termination and cancellation rights, if any; |
|
● |
whether there are any backstop or standby purchaser or purchasers and the terms of their commitment, if any; |
|
● |
whether stockholders are entitled to oversubscription rights, if any; |
|
● |
any applicable material U.S. federal income tax considerations; and |
|
● |
any other terms of the rights, including terms, procedures and limitations relating to the distribution, exchange and exercise of the rights, as applicable. |
Each right will entitle the
holder of rights to purchase for cash the principal amount of shares of common stock, preferred stock or other securities at the exercise
price provided in the applicable prospectus supplement. Rights may be exercised at any time up to the close of business on the expiration
date for the rights provided in the applicable prospectus supplement.
Holders may exercise rights
as described in the applicable prospectus supplement. Upon receipt of payment and the rights certificate properly completed and duly executed
at the corporate trust office of the rights agent or any other office indicated in the prospectus supplement, we will, as soon as practicable,
forward the shares of common stock, preferred stock or other securities, as applicable, purchasable upon exercise of the rights. If less
than all of the rights issued in any rights offering are exercised, we may offer any unsubscribed securities directly to persons other
than stockholders, to or through agents, underwriters or dealers or through a combination of such methods, including pursuant to standby
arrangements, as described in the applicable prospectus supplement.
Rights Agent
The rights agent for any rights
we offer will be set forth in the applicable prospectus supplement.
DESCRIPTION OF UNITS
The following description,
together with the additional information we may include in any applicable prospectus supplements and free writing prospectuses, summarizes
the material terms and provisions of the units that we may offer under this prospectus.
While the terms we have summarized
below will apply generally to any units that we may offer under this prospectus, we will describe the particular terms of any series of
units in more detail in the applicable prospectus supplement. The terms of any units offered under a prospectus supplement may differ
from the terms described below. However, no prospectus supplement will fundamentally change the terms that are set forth in this prospectus
or offer a security that is not registered and described in this prospectus at the time of its effectiveness.
We will file as exhibits to
the registration statement of which this prospectus is a part, or will incorporate by reference from a Current Report on Form 8-K
that we file with the SEC, the form of unit agreement that describes the terms of the series of units we are offering, and any supplemental
agreements, before the issuance of the related series of units. The following summaries of material terms and provisions of the units
are subject to, and qualified in their entirety by reference to, all the provisions of the unit agreement and any supplemental agreements
applicable to a particular series of units. We urge you to read the applicable prospectus supplements related to the particular series
of units that we sell under this prospectus, as well as the complete unit agreement and any supplemental agreements that contain the terms
of the units.
General
We may issue units comprised
of one or more debt securities, shares of common stock, shares of preferred stock and warrants in any combination. Each unit will be issued
so that the holder of the unit is also the holder of each security included in the unit. Thus, the holder of a unit will have the rights
and obligations of a holder of each included security. The unit agreement under which a unit is issued may provide that the securities
included in the unit may not be held or transferred separately, at any time or at any time before a specified date.
We will describe in the applicable
prospectus supplement the terms of the series of units, including:
|
● |
the designation and terms of the units and of the securities comprising the units, including whether and under what circumstances those securities may be held or transferred separately; |
|
● |
any provisions of the governing unit agreement that differ from those described below; and |
|
● |
any provisions for the issuance, payment, settlement, transfer or exchange of the units or of the securities comprising the units. |
The provisions described in
this section, as well as those described under “Description of Capital Stock,” “Description of Debt Securities”
and “Description of Warrants” will apply to each unit and to any common stock, preferred stock, debt security or warrant
included in each unit, respectively.
Unit Agent
The name and address of the
unit agent, if any, for any units we offer will be set forth in the applicable prospectus supplement.
Issuance in Series
We may issue units in such
amounts and in numerous distinct series as we determine.
Enforceability of Rights by Holders of Units
Each unit agent will act solely
as our agent under the applicable unit agreement and will not assume any obligation or relationship of agency or trust with any holder
of any unit. A single bank or trust company may act as unit agent for more than one series of units. A unit agent will have no duty or
responsibility in case of any default by us under the applicable unit agreement or unit, including any duty or responsibility to initiate
any proceedings at law or otherwise, or to make any demand upon us. Any holder of a unit may, without the consent of the related unit
agent or the holder of any other unit, enforce by appropriate legal action its rights as holder under any security included in the unit.
We, the unit agents and any
of their agents may treat the registered holder of any unit certificate as an absolute owner of the units evidenced by that certificate
for any purpose and as the person entitled to exercise the rights attaching to the units so requested, despite any notice to the contrary.
See “Legal Ownership of Securities.”
LEGAL OWNERSHIP OF SECURITIES
We can issue securities in
registered form or in the form of one or more global securities. We describe global securities in greater detail below. We refer to those
persons who have securities registered in their own names on the books that we or any applicable trustee or depositary or warrant agent
maintain for this purpose as the “holders” of those securities. These persons are the legal holders of the securities. We
refer to those persons who, indirectly through others, own beneficial interests in securities that are not registered in their own names,
as “indirect holders” of those securities. As we discuss below, indirect holders are not legal holders, and investors in securities
issued in book-entry form or in street name will be indirect holders.
Book-Entry Holders
We may issue securities in
book-entry form only, as we will specify in the applicable prospectus supplement. This means securities may be represented by one or more
global securities registered in the name of a financial institution that holds them as depositary on behalf of other financial institutions
that participate in the depositary’s book-entry system. These participating institutions, which are referred to as participants,
in turn, hold beneficial interests in the securities on behalf of themselves or their customers.
Only the person in whose name
a security is registered is recognized as the holder of that security. Global securities will be registered in the name of the depositary
or its participants. Consequently, for global securities, we will recognize only the depositary as the holder of the securities, and we
will make all payments on the securities to the depositary. The depositary passes along the payments it receives to its participants,
which in turn pass the payments along to their customers who are the beneficial owners. The depositary and its participants do so under
agreements they have made with one another or with their customers; they are not obligated to do so under the terms of the securities.
As a result, investors in
a global security will not own securities directly. Instead, they will own beneficial interests in a global security, through a bank,
broker or other financial institution that participates in the depositary’s book-entry system or holds an interest through a participant.
As long as the securities are issued in global form, investors will be indirect holders, and not legal holders, of the securities.
Street Name Holders
We may terminate a global
security or issue securities that are not issued in global form. In these cases, investors may choose to hold their securities in their
own names or in “street name.” Securities held by an investor in street name would be registered in the name of a bank, broker
or other financial institution that the investor chooses, and the investor would hold only a beneficial interest in those securities through
an account he or she maintains at that institution.
For securities held in street
name, we or any applicable trustee or depositary will recognize only the intermediary banks, brokers and other financial institutions
in whose names the securities are registered as the holders of those securities, and we or any such trustee or depositary will make all
payments on those securities to them. These institutions pass along the payments they receive to their customers who are the beneficial
owners, but only because they agree to do so in their customer agreements or because they are legally required to do so. Investors who
hold securities in street name will be indirect holders, not legal holders, of those securities.
Legal Holders
Our obligations, as well as
the obligations of any applicable trustee or third party employed by us or a trustee, run only to the legal holders of the securities.
We do not have obligations to investors who hold beneficial interests in global securities, in street name or by any other indirect means.
This will be the case whether an investor chooses to be an indirect holder of a security or has no choice because we are issuing the securities
only in global form.
For example, once we make
a payment or give a notice to the holder, we have no further responsibility for the payment or notice even if that holder is required,
under agreements with its participants or customers or by law, to pass it along to the indirect holders but does not do so. Similarly,
we may want to obtain the approval of the holders to amend an indenture, to relieve us of the consequences of a default or of our obligation
to comply with a particular provision of an indenture, or for other purposes. In such an event, we would seek approval only from the legal
holders, and not the indirect holders, of the securities. Whether and how the legal holders contact the indirect holders is up to the
legal holders.
Special Considerations for Indirect Holders
If you hold securities through
a bank, broker or other financial institution, either in book-entry form because the securities are represented by one or more global
securities or in street name, you should check with your own institution to find out:
|
● |
how it handles securities payments and notices; |
|
● |
whether it imposes fees or charges; |
|
● |
how it would handle a request for the holders’ consent, if ever required; |
|
● |
whether and how you can instruct it to send you securities registered in your own name so you can be a legal holder, if that is permitted in the future; |
|
● |
how it would exercise rights under the securities if there were a default or other event triggering the need for holders to act to protect their interests; and |
|
● |
if the securities are in book-entry form, how the depositary’s rules and procedures will affect these matters. |
Global Securities
A global security is a security
that represents one or any other number of individual securities held by a depositary. Generally, all securities represented by the same
global securities will have the same terms.
Each security issued in book-entry
form will be represented by a global security that we issue to, deposit with and register in the name of a financial institution or its
nominee that we select. The financial institution that we select for this purpose is called the depositary. Unless we specify otherwise
in the applicable prospectus supplement, The Depository Trust Company, New York, NY, known as DTC, will be the depositary for all securities
issued in book-entry form.
A global security may not
be transferred to or registered in the name of anyone other than the depositary, its nominee or a successor depositary, unless special
termination situations arise. We describe those situations below under “— Special Situations When A Global Security
Will Be Terminated.” As a result of these arrangements, the depositary, or its nominee, will be the sole registered owner and legal
holder of all securities represented by a global security, and investors will be permitted to own only beneficial interests in a global
security. Beneficial interests must be held by means of an account with a broker, bank or other financial institution that in turn has
an account with the depositary or with another institution that does. Thus, an investor whose security is represented by a global security
will not be a legal holder of the security, but only an indirect holder of a beneficial interest in the global security.
If the prospectus supplement
for a particular security indicates that the security will be issued as a global security, then the security will be represented by a
global security at all times unless and until the global security is terminated. If termination occurs, we may issue the securities through
another book-entry clearing system or decide that the securities may no longer be held through any book-entry clearing system.
Special Considerations For Global Securities
As an indirect holder, an
investor’s rights relating to a global security will be governed by the account rules of the investor’s financial institution
and of the depositary, as well as general laws relating to securities transfers. We do not recognize an indirect holder as a holder of
securities and instead deal only with the depositary that holds the global security.
If securities are issued only
as global securities, an investor should be aware of the following:
|
● |
an investor cannot cause the securities to be registered in his or her name, and cannot obtain non-global certificates for his or her interest in the securities, except in the special situations we describe below; |
|
● |
an investor will be an indirect holder and must look to his or her own bank or broker for payments on the securities and protection of his or her legal rights relating to the securities, as we describe above; |
|
● |
an investor may not be able to sell interests in the securities to some insurance companies and to other institutions that are required by law to own their securities in non-book-entry form; |
|
● |
an investor may not be able to pledge his or her interest in the global security in circumstances where certificates representing the securities must be delivered to the lender or other beneficiary of the pledge in order for the pledge to be effective; |
|
● |
the depositary’s policies, which may change from time to time, will govern payments, transfers, exchanges and other matters relating to an investor’s interest in the global security. We and any applicable trustee have no responsibility for any aspect of the depositary’s actions or for its records of ownership interests in the global security. We and the trustee also do not supervise the depositary in any way; |
|
● |
the depositary may, and we understand that DTC will, require that those who purchase and sell interests in the global security within its book-entry system use immediately available funds, and your broker or bank may require you to do so as well; and |
|
● |
financial institutions that participate in the depositary’s book-entry system, and through which an investor holds its interest in the global security, may also have their own policies affecting payments, notices and other matters relating to the securities. There may be more than one financial intermediary in the chain of ownership for an investor. We do not monitor and are not responsible for the actions of any of those intermediaries |
Special Situations When A Global Security Will
Be Terminated
In a few special situations
described below, a global security will terminate and interests in it will be exchanged for physical certificates representing those interests.
After that exchange, the choice of whether to hold securities directly or in street name will be up to the investor. Investors must consult
their own banks or brokers to find out how to have their interests in securities transferred to their own names, so that they will be
direct holders. We have described the rights of holders and street name investors above.
A global security will terminate
when the following special situations occur:
|
● |
if the depositary notifies us that it is unwilling, unable or no longer qualified to continue as depositary for that global security and we do not appoint another institution to act as depositary within 90 days; |
|
● |
if we notify any applicable trustee that we wish to terminate that global security; or |
|
● |
if an event of default has occurred with regard to securities represented by that global security and has not been cured or waived. |
The applicable prospectus
supplement may also list additional situations for terminating a global security that would apply only to the particular series of securities
covered by the prospectus supplement. When a global security terminates, the depositary, and neither we, nor any applicable trustee, is
responsible for deciding the names of the institutions that will be the initial direct holders.
PLAN OF DISTRIBUTION
We may sell the securities
being offered hereby in one or more of the following ways from time to time:
|
● |
through agents to the public or to investors; |
|
● |
to underwriters for resale to the public or to investors; |
|
● |
negotiated transactions; |
|
● |
directly to investors; or |
|
● |
through a combination of any of these methods of sale. |
As set forth in more detail
below, the securities may be distributed from time to time in one or more transactions:
|
● |
at a fixed price or prices, which may be changed; |
|
● |
at market prices prevailing at the time of sale; |
|
● |
at prices related to such prevailing market prices; or |
We will set forth in a prospectus
supplement the terms of that particular offering of securities, including:
|
● |
the name or names of any agents or underwriters; |
|
● |
the purchase price of the securities being offered and the proceeds we will receive from the sale; |
|
● |
any over-allotment options under which underwriters may purchase additional securities from us; |
|
● |
any agency fees or underwriting discounts and other items constituting agents’ or underwriters’ compensation; |
|
● |
any initial public offering price; |
|
● |
any discounts or concessions allowed or re-allowed or paid to dealers; and |
|
● |
any securities exchanges or markets on which such securities may be listed. |
Only underwriters named in
an applicable prospectus supplement are underwriters of the securities offered by that prospectus supplement.
If underwriters are used in
an offering, we will execute an underwriting agreement with such underwriters and will specify the name of each underwriter and the terms
of the transaction (including any underwriting discounts and other terms constituting compensation of the underwriters and any dealers)
in a prospectus supplement. The securities may be offered to the public either through underwriting syndicates represented by managing
underwriters or directly by one or more investment banking firms or others, as designated. If an underwriting syndicate is used, the managing
underwriter(s) will be specified on the cover of the prospectus supplement. If underwriters are used in the sale, the offered securities
will be acquired by the underwriters for their own accounts and may be resold from time to time in one or more transactions, including
negotiated transactions, at a fixed public offering price or at varying prices determined at the time of sale. Any public offering price
and any discounts or concessions allowed or re-allowed or paid to dealers may be changed from time to time. Unless otherwise set forth
in the prospectus supplement, the obligations of the underwriters to purchase the offered securities will be subject to conditions precedent
and the underwriters will be obligated to purchase all of the offered securities if any are purchased.
We may grant to the underwriters
options to purchase additional securities to cover over-allotments, if any, at the public offering price, with additional underwriting
commissions or discounts, as may be set forth in a related prospectus supplement. The terms of any over-allotment option will be set forth
in the prospectus supplement for those securities.
If we use a dealer in the
sale of the securities being offered pursuant to this prospectus or any prospectus supplement, we will sell the securities to the dealer,
as principal. The dealer may then resell the securities to the public at varying prices to be determined by the dealer at the time of
resale. The names of the dealers and the terms of the transaction will be specified in a prospectus supplement.
We may sell the securities
directly or through agents we designate from time to time. We will name any agent involved in the offering and sale of securities and
we will describe any commissions we will pay the agent in the prospectus supplement. Unless the prospectus supplement states otherwise,
any agent will act on a best-efforts basis for the period of its appointment.
We may authorize agents or
underwriters to solicit offers by institutional investors to purchase securities from us at the public offering price set forth in the
prospectus supplement pursuant to delayed delivery contracts providing for payment and delivery on a specified date in the future. We
will describe the conditions to these contracts and the commissions we must pay for solicitation of these contracts in the prospectus
supplement.
In connection with the sale
of the securities, underwriters, dealers or agents may receive compensation from us or from purchasers of the common stock for whom they
act as agents in the form of discounts, concessions or commissions. Underwriters may sell the securities to or through dealers, and those
dealers may receive compensation in the form of discounts, concessions or commissions from the underwriters or commissions from the purchasers
for whom they may act as agents. Underwriters, dealers and agents that participate in the distribution of the securities, and any institutional
investors or others that purchase common stock directly and then resell the securities, may be deemed to be underwriters, and any discounts
or commissions received by them from us and any profit on the resale of the common stock by them may be deemed to be underwriting discounts
and commissions under the Securities Act.
We may provide agents and
underwriters with indemnification against particular civil liabilities, including liabilities under the Securities Act, or contribution
with respect to payments that the agents or underwriters may make with respect to such liabilities. Agents and underwriters may engage
in transactions with, or perform services for, us in the ordinary course of business.
We may engage in at the market
offerings into an existing trading market in accordance with Rule 415(a)(4) under the Securities Act. In addition, we may enter into derivative
transactions with third parties (including the writing of options), or sell securities not covered by this prospectus to third parties
in privately negotiated transactions. If the applicable prospectus supplement indicates, in connection with such a transaction, the third
parties may, pursuant to this prospectus and the applicable prospectus supplement, sell securities covered by this prospectus and the
applicable prospectus supplement. If so, the third party may use securities borrowed from us or others to settle such sales and may use
securities received from us to close out any related short positions. We may also loan or pledge securities covered by this prospectus
and the applicable prospectus supplement to third parties, who may sell the loaned securities or, in an event of default in the case of
a pledge, sell the pledged securities pursuant to this prospectus and the applicable prospectus supplement. The third party in such sale
transactions will be an underwriter and will be identified in the applicable prospectus supplement or in a post-effective amendment.
To facilitate an offering
of a series of securities, persons participating in the offering may engage in transactions that stabilize, maintain, or otherwise affect
the market price of the securities. This may include over-allotments or short sales of the securities, which involves the sale by persons
participating in the offering of more securities than have been sold to them by us. In those circumstances, such persons would cover such
over-allotments or short positions by purchasing in the open market or by exercising the over-allotment option granted to those persons.
In addition, those persons may stabilize or maintain the price of the securities by bidding for or purchasing securities in the open market
or by imposing penalty bids, whereby selling concessions allowed to underwriters or dealers participating in any such offering may be
reclaimed if securities sold by them are repurchased in connection with stabilization transactions. The effect of these transactions may
be to stabilize or maintain the market price of the securities at a level above that which might otherwise prevail in the open market.
Such transactions, if commenced, may be discontinued at any time. We make no representation or prediction as to the direction or magnitude
of any effect that the transactions described above, if implemented, may have on the price of our securities.
Unless otherwise specified
in the applicable prospectus supplement, each class or series of securities will be a new issue with no established trading market, other
than our common stock, which is listed on The Nasdaq Capital Market. We may elect to list any other class or series of securities on any
exchange or market, but we are not obligated to do so. It is possible that one or more underwriters may make a market in a class or series
of securities, but the underwriters will not be obligated to do so and may discontinue any market making at any time without notice. We
cannot give any assurance as to the liquidity of the trading market for any of the securities.
In order to comply with the
securities laws of some U.S. states or territories, if applicable, the securities offered pursuant to this prospectus will be sold in
those states only through registered or licensed brokers or dealers. In addition, in some states securities may not be sold unless they
have been registered or qualified for sale in the applicable state or an exemption from the registration or qualification requirement
is available and complied with.
Any underwriter may engage
in overallotment, stabilizing transactions, short covering transactions and penalty bids in accordance with Regulation M under the Securities
Exchange Act of 1934, as amended (the “Exchange Act”). Overallotment involves sales in excess of the offering size, which
create a short position. Stabilizing transactions permit bids to purchase the underlying security so long as the stabilizing bids do not
exceed a specified maximum. Short covering transactions involve purchases of the securities in the open market after the distribution
is completed to cover short positions. Penalty bids permit the underwriters to reclaim a selling concession from a dealer when the securities
originally sold by the dealer are purchased in a covering transaction to cover short positions. Those activities may cause the price of
the securities to be higher than it would otherwise be. If commenced, the underwriters may discontinue any of these activities at any
time.
Any underwriters who are qualified
market makers on The Nasdaq Capital Market may engage in passive market making transactions in the securities on The Nasdaq Capital Market
in accordance with Rule 103 of Regulation M, during the business day prior to the pricing of the offering, before the commencement
of offers or sales of the securities. Passive market makers must comply with applicable volume and price limitations and must be identified
as passive market makers. In general, a passive market maker must display its bid at a price not in excess of the highest independent
bid for such security. If all independent bids are lowered below the passive market maker’s bid, however, the passive market maker’s
bid must then be lowered when certain purchase limits are exceeded.
LEGAL MATTERS
The validity of the issuance
of the securities offered hereby will be passed upon for us by Sheppard, Mullin, Richter & Hampton LLP, New York, NY. Additional legal
matters may be passed upon for us or any underwriters, dealers or agents, by counsel that we will name in the applicable prospectus supplement.
EXPERTS
The
financial statements of Amesite Inc. incorporated in this Prospectus by reference to Amesite Inc.’s annual report on Form 10-K for
the year ended June 30, 2021, have been audited by Deloitte & Touche LLP, an independent registered public accounting firm, as stated
in their report. Such financial statements have been so incorporated in reliance upon the report of such firm given upon their authority
as experts in accounting and auditing.
WHERE YOU CAN FIND MORE INFORMATION
This prospectus constitutes
a part of a registration statement on Form S-3 filed under the Securities Act. As permitted by the SEC’s rules, this prospectus
and any prospectus supplement, which form a part of the registration statement, do not contain all the information that is included
in the registration statement. You will find additional information about us in the registration statement. Any statements made in this
prospectus or any prospectus supplement concerning legal documents are not necessarily complete and you should read the documents that
are filed as exhibits to the registration statement or otherwise filed with the SEC for a more complete understanding of the document
or matter.
You may read and copy the
registration statement, as well as our reports, proxy statements, and other information, at the SEC’s Public Reference Room at 100
F Street, N.E., Washington, D.C. 20549. Please call the SEC at 1-800-SEC-0330 for more information about the operation of the Public Reference
Room. The SEC maintains an Internet site that contains reports, proxy and information statements, and other information regarding issuers
that file electronically with the SEC. The SEC’s Internet site can be found at http://www.sec.gov. You can also obtain copies of
materials we file with the SEC from our website found at www.amesite.com. Information on our website does not constitute a part of, nor
is it incorporated in any way, into this prospectus and should not be relied upon in connection with making an investment decision.
INCORPORATION OF DOCUMENTS BY REFERENCE
We have filed a registration
statement on Form S-3 with the U.S. Securities and Exchange Commission (the “SEC”) under the Securities Act of 1933,
as amended. This prospectus is part of the registration statement, however the registration statement includes and incorporates by reference
additional information and exhibits. The SEC permits us to “incorporate by reference” the information contained in documents
we file with the SEC, which means that we can disclose important information to you by referring you to those documents rather than by
including them in this prospectus. Information that is incorporated by reference is considered to be part of this prospectus and you should
read it with the same care that you read this prospectus. Information that we file later with the SEC will automatically update and supersede
the information that is either contained, or incorporated by reference, in this prospectus, and will be considered to be a part of this
prospectus from the date those documents are filed. We have filed with the SEC, and hereby incorporate by reference in this prospectus:
|
(a) |
Our Annual Report on Form 10-K for the fiscal year ended June 30, 2021 filed with the SEC on September 10, 2021; |
|
(b) |
Our
Current Report on Form 8-K filed with the SEC on September 14, 2021; |
|
(c) |
Our
Definitive Proxy Statement on Schedule 14A for our 2021 Annual Meeting of Stockholders, filed with the Commission on October 1, 2021;
and |
|
(d) |
The
description of our common stock contained in the registration statement on Form 8-A filed with the SEC on September 23, 2020, including
any amendment or report filed for the purpose of updating that description. |
We also incorporate by reference
all documents (other than Current Reports furnished under Item 2.02 or Item 7.01 of Form 8-K and exhibits filed on such form that are
related to such items) that are subsequently filed by us with SEC pursuant to Sections 13(a), 13(c), 14, or 15(d) of the Exchange
Act prior to the termination of the offering of the securities made by this prospectus (including documents filed after the date of the
initial Registration Statement of which this prospectus is a part and prior to the effectiveness of the Registration Statement). These
documents include periodic reports, such as Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K,
as well as proxy statements.
Any statement contained in
this prospectus or in a document incorporated or deemed to be incorporated by reference into this prospectus will be deemed to be modified
or superseded to the extent that a statement contained in this prospectus or any subsequently filed document that is deemed to be incorporated
by reference into this prospectus modifies or supersedes the statement
You may request, and we will
provide you with, a copy of these filings, at no cost, by calling us at (734) 876-8130 or by writing to us at the following address:
Amesite Inc.
607 Shelby Street, Suite 700 PMB 214
Detroit, MI 48226
(734) 876-8130
31
Amesite (NASDAQ:AMST)
Historical Stock Chart
From Mar 2024 to Apr 2024
Amesite (NASDAQ:AMST)
Historical Stock Chart
From Apr 2023 to Apr 2024